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A B S T R A C T
Background
Anterior cruciate ligament (ACL) tears are frequently treated with surgical reconstruction with grafts, frequently patella tendon or
hamstrings. Interference screws are often used to secure the graft in bone tunnels in the femur and tibia. This review examines whether
bioabsorbable interference screws give better results than metal interference screws when used for graft fixation in ACL reconstruction.
Objectives
To assess the effects (benefits and harms) of bioabsorbable versus metallic interference screws for graft fixation in ACL reconstruction.
Search methods
We searched theCochrane Bone, Joint andMuscle TraumaGroup SpecialisedRegister, CENTRAL (theCochrane Library),MEDLINE,
Embase, LILACS, trial registers and reference lists of articles. Date of search: January 2016.
Selection criteria
We included randomised controlled trials and quasi-randomised trials comparing bioabsorbable with metallic interferences screws in
ACL reconstruction. The main outcomes sought were subjective-rated knee function, failure of treatment, and activity level.
Data collection and analysis
At least two review authors selected eligible trials, independently assessed risk of bias, and cross-checked data.Data were pooledwhenever
relevant and possible. Requests for further information were sent to the original study authors.
Main results
We included 12 trials (11 randomised and one quasi-randomised) involving a total of 944 participants, and reporting follow-up results
for 774. Participants in the 12 trials underwent ACL reconstruction with either hamstring tendon grafts (five trials) or patellar tendon
grafts (seven trials). Trials participants were randomly allocated to bioabsorbable or metallic interference screws for graft fixation in
both femur and tibia (seven trials); femur only (three trials); tibia only (one trial); location was not reported in the remaining trial. A
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variety of materials was used for the bioabsorbable screws, Poly-L-lactic acid (PLLA) being the most common. The metallic screws,
where reported, were titanium.
All trials were at high risk of bias, which invariably included performance bias. Seven trials were at high risk of attrition bias and eight
at high risk of reporting bias. The quasi-randomised trial was assessed as being at high risk for selection bias. Based on these study
limitations and insufficiency of the available data, we judged the quality of evidence for all outcomes was very low.
The majority of the available data for patient-reported knee function was presented as Lysholm scores (0 to 100; higher scores = better
function). There was very low quality but consistent evidence of no clinically important differences between the two groups in Lysholm
scores at 12 months follow-up (mean difference (MD) -0.08, 95% confidence interval (CI) -1.48 to 1.32; three trials, 168 participants);
24 months (MD 0.35, 95% CI -1.27 to 1.98; three trials, 113 participants) or five or more years follow-up (MD 1.23, 95% CI -2.00
to 4.47; two trials, 71 participants). This lack of between-group differences was also reported for Lysholm scores in several trials that
did not provide sufficient data for pooling as well as for other self-reported knee function scores reported in several trials.
Treatment failure was represented by the summed data for implant breakage during surgery and major postoperative complications
(implant failure, graft rupture, symptomatic foreign body reactions, effusion and treated arthrofibrosis and related conditions) that were
usually described in the trial reports as requiring further substantive treatment. There is very low-quality evidence of greater treatment
failure in the bioabsorbable screw group (60/451 versus 29/434; risk ratio (RR) 1.94 favouring metallic screw fixation, 95% CI 1.29 to
2.93; 885 participants, 11 studies). In a population with an assumed risk (based on the median control group risk) of 56 participants
per 1000 having treatment failure after metallic screw fixation, this equates to 53 more (95% CI 17 to 108 more) per 1000 participants
having treatment failure after bioabsorbable screw fixation. All 16 intraoperative complications in the bioabsorbable screw group were
implant breakages upon screw insertion. Treatment failure defined as postoperative complications only still favoured the metallic screw
group but the 95% CI also included the potential for a greater risk of treatment failure after metallic screw fixation: 44/451 versus 29/
434; RR 1.44, 95% CI 0.93 to 2.23. Based on the assumed risk of 56 participants per 1000 having postoperative treatment failure
after metallic screw fixation, this equates to 25 more (95% CI 4 fewer and 69 more) per 1000 participants having this outcome after
bioabsorbable screw fixation.
There was very low-quality evidence of very similar activity levels in the two groups at 12 and 24 months follow-up measured via the
Tegner score (0 to 10; higher scores = greater activity): 12 months (MD 0.08, 95% CI -0.39 to 0.55; 122 participants, two studies);
24 months (MD 0.01, 95% CI -0.54 to 0.57; 72 participants, two studies).
Authors’ conclusions
There is very low-quality evidence of no difference in self-reported knee function and levels of activity between bioabsorbable and
metallic interference screws for graft fixation in ACL reconstruction. There is very low-quality evidence that bioabsorbable screws may
be associated with more overall treatment failures, including implant breakage during surgery. Further research does not appear to be
a priority, but if undertaken, should also examine costs.
P L A I N L A N G U A G E S U M M A R Y
Bioabsorbable versus metal screw for graft fixation in the surgical treatment of anterior cruciate ligament injury
Background
The anterior cruciate ligament (ACL) is a knee ligament that functions to stabilise the knee. ACL injuries are more common in athletes,
such as football, basketball and handball players. Many people with ACL injuries are treated with surgery to reconstruct this ligament.
In ACL reconstruction, a replacement ligament (graft) is attached to tunnels drilled into the end of the femur (thigh bone) and tibia
(shin bone). Often screws are used to attach the graft to the bone. Traditionally, metal screws have been used. Although these are
generally successful, metallic screws can be hard to remove if further surgery is required. They also interfere with looking at the knee
using magnetic resonance imaging (MRI). With the aim of avoiding these disadvantages, and in response to patient requests, screws
made from materials that dissolve over time (bioabsorbable screws) were introduced. However, such screws have been reported to
have increased risks of inflammation, infection, and failed surgery.
Results of the search
We searchedmedical databases up to January 2016 for randomised studies comparing bioabsorbable with metal screws for graft fixation.
We included 12 studies involving 944 participants undergoing surgery (ACL reconstruction).
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Key results
We found evidence that self-reported measures of knee function were similar at one, two and five of more years in those treated whose
grafts were fixed with bioabsorbable screws to those whose grafts were fixed with metal screws. Similarly, no differences were seen
between the two types of screws in levels of activity at one and two years. However, there was evidence that bioabsorbable screws may
be associated with more treatment failures. These include screw breakage during surgery, and greater numbers of graft rupture.
Quality of the evidence
All 12 studies had weaknesses that could affect the reliability of their results. We considered the evidence was very low quality meaning
that we are unsure of these results.
Conclusions
The limited evidence does not show that knee function and activity levels are any better after bioabsorbable screws compared with
metal screws. However, such screws may break during surgery and may result in a greater risk of later treatment failure. Further research
does not appear to be a priority but if undertaken should also examine costs.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Bioabsorbable interference screws compared with metallic interference screws for graft fixation in ACL reconstruction
Patient or population: Adults undergoing surgical reconstruct ion of a ruptured ACL1
Settings: Hospital operat ing theatre
Intervention: Bioabsorbable interference screws2 f or graf t f ixat ion3
Comparison: Metallic interference screws (t itanium, where recorded) for graf t f ixat ion3
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Metallic screw Bioabsorbable screw
Function:
Lysholm knee score (0
to 100; higher scores =
better function)
Follow-up: 12 months
The mean Lysholm
score ranged across
control groups f rom
91 to 97.3
The mean Lysholm
score in the interven-
t ion groups was
0.08 lower
(1.48 lower to 1.32
higher)
168
(3 studies)
⊕©©©
very low4
A sim ilar lack of stat is-
t ically signif icant and
clinically important dif -
ferences in Lysholm
scores at 12 months
was found in one
other trial (24 part ic-
ipants). Trials report-
ing other measures of
self -reported funct ion
also showed a lack
of between-group dif -
ferences: 2 trials (149
part icipants)
Function:
Lysholm knee score (0
to 100; higher scores =
better function)
Follow-up: 24 months
The mean Lysholm
score ranged across
control groups f rom
90 to 96
The mean Lysholm
score in the interven-
t ion groups was
0.35 higher
(1.27 lower to 1.98
higher)
113
(3 studies)
⊕©©©
very low4
A sim ilar lack of stat is-
t ically signif icant and
clinically important dif -
ferences in Lysholm
scores at 24 months
was found in two other
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t rials (168 part icipants)
Trials report ing other
measures of self -re-
ported funct ion also
showed a lack of
between-group dif fer-
ences: 2 trials (77 par-
t icipants)
Function:
Lysholm knee score (0
to 100; higher scores =
better function)
Follow-up: 5 years or
more
The mean Lysholm
score ranged across
control groups f rom
90 to 92
The mean Lysholm
score in the interven-
t ion groups was
1.23 higher
(2.00 lower to 4.47
higher)
71
(2 studies)
⊕©©©
very low4
A sim ilar lack of stat is-
t ically signif icant and
clinically important dif -
ferences in Lysholm
scores at 8 years was
found in one other trial
(64 part icipants)
Overall treatment fail-
ure - Intraoperative and
postoperative
complications5
Follow-up: range opera-
t ive up to 7 years
56 per 10006 100 per 1000
(73 to 164)
RR
1.94 (1.29 to 2.93)
885
(11 studies)
⊕©©©
very low4
Intraoperat ive compli-
cat ions were 16 break-
age of bioabsorbable
screws upon insert ion
and one loosening of
a metallic screw. Sen-
sit ivity analyses re-
moving the dominant
trial which reported 12
screw breakages or
just report ing the tri-
als with secure alloca-
t ion concealment st ill
f avoured the metallic
screw group
Overall treatment fail-
ure - Postoperative
complications7
Follow-up: range post-
operat ive up to 7 years
56 per 10006 81 per 1000
(52 to 125)
RR 1.44 (0.93 to 2.23) 885
(11 studies)
⊕©©©
very low4
Note the 95% CI
crosses the line of
no ef fect and thus in-
cludes the possibility of
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a greater failure rate
in the metallic screw
group
Graf t rupture occurred
twice as of ten in the
bioabsorbable group:
12/ 332 versus 6/ 299;
RR 1.70, 95% CI 0.
69 to 4.19. The dif fer-
ence was not stat ist i-
cally signif icant: P = 0.
25
Activity level: Tegner
score ( 0 to 10; higher
scores = greater activ-
ity)
Follow-up = 12 months
The mean Tegner score
ranged across control
groups f rom
5.7 to 7.1
The mean Tegner score
in the intervent ion
groups was 0.08 higher
(0.39 lower to 0.55
higher)
122
(2 studies)
⊕©©©
very low4
Another trial (34 part ic-
ipants) found a stat is-
t ically non signif icant
dif f erence in Tegner
scores in favour of the
metallic screw group at
12 months
Activity level: Tegner
score ( 0 to 10; higher
scores = greater activ-
ity)
Follow-up = 24 months
The mean Tegner score
ranged across control
groups f rom
6.2 to 7.5
The mean Tegner score
in the intervent ion
groups was 0.01 higher
(0.54 lower to 0.57
higher)
72
(2 studies)
⊕©©©
very low4
Another trial (34 part ic-
ipants) found a stat ist i-
cally signif icant dif f er-
ence in Tegner scores
of approximately 1.0 -
data read of f graph -
in favour of the metal-
lic screw group at 24
months
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval; RR: Risk Ratio
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1. Graf ts used in the included trials were either hamstring or patellar tendons
2. A variety of materials was used: Poly-L-lact ic acid (PLLA) was the most common
3. The randomised screws were used both in the femur and t ibia in 7 trials, in the femur only in 3 trials and in the t ibia only in
1 trial; unknown locat ion in 1 trial
4. The evidence was downgraded two levels for major study lim itat ions, ref lect ing high risks of performance bias and attrit ion
bias, and one level for imprecision, ref lect ing small sample sizes
5. Summed data for implant breakage during surgery and major postoperat ive complicat ions (implant failure, graf t rupture,
symptomatic foreign body react ions, ef fusion and treated arthrof ibrosis and related condit ions) that were usually described
in the trial reports as requiring further substant ive treatment.
6. Assumed risk is the median control risk across studies
7. Summed data for major postoperat ive complicat ions (implant failure, graf t rupture, symptomatic foreign body react ions,
ef fusion and treated arthrof ibrosis and related condit ions) that were usually described in the trial reports as requiring further
substant ive treatment.
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B A C K G R O U N D
Description of the condition
The anterior cruciate ligament (ACL) is a tough band of fibrous
connective tissue located within the knee joint that connects the
femur (thigh bone) with the tibia (shin bone). Its primary function
is to prevent the tibia from moving forward relative to the femur.
It also restrains rotation of the tibia (Insall 2006).
ACL injuries, which generally occur in people participating in
high-risk activities such as football, basketball, handball, or ski-
ing, commonly involve a complete rupture of the ligament. Many
people with these injuries are treated surgically by reconstruct-
ing the ligament with a graft, which can be taken from various
sources. Graft choices include autografts, which are harvested from
the patient, and allografts, which are grafts from cadavers. Auto-
graft sources include the patellar tendon or quadriceps tendon (at
the front of the knee) and hamstring tendons (at the back of the
knee). ACL reconstruction is a common procedure that aims to
restore knee function and stability and lessen the risk of subse-
quent knee injuries. Approximately 100,000 ACL reconstructions
are performed each year in the United States (Griffin 2000).
Description of the intervention
ACL reconstruction is usually performed arthroscopically with
small incisions. There are various methods of ACL reconstruc-
tion. The procedure generally involves drilling tunnels into the
tibia and femur to place the ACL graft in a similar position to
the native ACL. The graft is pulled up through the tibial tunnel
and into the femoral tunnel. Once in position, the graft is fixed
under tension using various devices. Due to its capacity to resist
cyclic movements, one of the most efficient fixation devices is the
interference screw. The interference screw is a conical threaded
device that is inserted into the bone tunnel, compressing the graft
against the tunnel walls and fixing it in the desired position. This
kind of screw can be used for both femoral and tibial fixation, al-
though it is more commonly used on the tibial side. An animation
demonstrating ACL reconstruction with a patellar tendon graft is
available (Zarins 2007).
Interference screws may be composed of metal or bioabsorbable
materials. Once in place, metal screws are generally not removed
unless there is an adverse event or removal is otherwise indicated.
The advent of bioabsorbable screws resulted in part from patient
preference for a device that disappears (Drogset 2005a). Bioab-
sorbablematerials include various polymers, such as polylactic acid
(PLA), poly-L-lactic acid (PLLA) or polyglycolic acid (PGA), all
of which degrade and are replaced by tissue over time.
How the intervention might work
Among the most frequent surgical complications related to ACL
reconstruction is arthrofibrosis, which is a restriction of knee mo-
tion in response to a fibrous scar tissue that forms when the joint
remains immobile for a long time. Because the success of surgery
depends on firm fixation of the reconstructed ligament in the ap-
propriate position, devices have been developed that maintain fix-
ation in spite of the early motion utilised in current postopera-
tive rehabilitation techniques. Allowing this rehabilitation to start
early and intensively without loss of fixation reduces the risk of
arthrofibrosis and other complications. Adequate fixation, such
as an interference screw, should hold the graft firmly in place for
at least eight weeks (Benedetto 2000a) while the graft integrates
with surrounding bone. Biomechanical studies generally have not
demonstrated the superiority of one screw type over the other in
regards to pullout strength (Johnson 1996; Nakano 2000; Nyland
2004; Pena 1996). In one study,Kousa 2003 concluded that bioab-
sorbable material performed better than metal in regard to initial
pullout strength.
It is imperative that the fixation device does not cause graft break-
age, damage or slippage; hardware symptoms requiring premature
removal; implant breakage; infection; or other problems. Bioab-
sorbable fixation could reduce the need for implant removal al-
though unabsorbed material has been found up to four years after
implantation (Ma 2004). Another possible advantage is that, un-
like metal screws, bioabsorbable screws do not interfere with post-
surgical magnetic resonance imaging (MRI). However, some au-
thors have reported increased incidence of synovitis (Fridén 1992)
and aseptic inflammatory (foreign body) reactions from the degra-
dation products of bioabsorbable screws (Böstman 1992; Weiler
1996). The potential for foreign body responses to bioabsorbable
materials seems to depend to some extent on the polymer used
(Kanon 2009). Generally, screw degradation should be accompa-
nied by bone replacement of the defect, however, the tissue re-
sponse accompanying this process is usually varied (Fink 2000).
According to Böstman 1992 , the implant might be gradually
replaced by connective tissue, newly formed trabecular bone and
bone marrow elements or there is a sleeve of cortical bone formed
that outlines the profile of the screw while the cavity is filled with
loose granulation tissue. This, though, could be advantageous in
the case of ACL revision surgery and could avoid the necessity of
using bone graft (Fink 2000).
Typically, metal screws cost less than bioabsorbable screws: for
example, the charges in 2016 in our hospital in Brazilian real are
R$ 984.00 versus R$ 1,409.00.
Why it is important to do this review
It remains unclear whether bioabsorbable screws give better results
than metal screws when used to reconstruct the ACL. This review
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aims to identify and appraise the best evidence available to answer
this question.
O B J E C T I V E S
To assess and compare the effects (benefits and harms) of bioab-
sorbable versus metallic interference screws for graft fixation in
anterior cruciate ligament (ACL) reconstruction.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials and quasi-randomised
trials (a trial in which the allocation is not strictly random: e.g.
by date of birth, hospital record number, alternation) comparing
anterior cruciate ligament (ACL) reconstruction with metallic or
bioabsorbable interference screws.
Types of participants
Adults undergoing surgical reconstruction of a ruptured ACL.
Types of interventions
Bioabsorbable interference screws (including polylactide (PLLA)
or polyglyconate screws) versus metallic interference screws (in-
cluding titanium screws) for graft fixation in any type of ACL re-
construction.
Types of outcome measures
Primary outcomes
1. Subjectively-rated knee function: wherever possible, we
used validated, patient-reported function measures for the knee
including those designed specifically for knee ligament injuries
(the International Knee Documentation Committee - IKDC)
(Irrgang 2001), the ACL Quality of Life outcome measure
(Mohtadi 1998), and the Lysholm score (Lysholm 1982)); and
those designed for the knee in general (Knee Injury and
Osteoarthritis Outcome Score - KOOS)
2. Failure of treatment and adverse events: implant breakage,
screw migration, graft loss or failure, need for revision surgery,
superficial and deep infections, and symptomatic foreign body
reactions. We also included arthrofibrosis, cyclops lesion and
adhesions that required further surgery
3. Activity level: measured by Tegner activity level and return
to sports, including time taken to resume sports
Secondary outcomes
1. Clinician-rated scores (IKDC objective score)
2. General quality of life general health measures such as the
SF-36
3. Objective functional tests (e.g. single-leg hop tests)
4. Knee laxity (where possible, using the KT-arthrometer)
5. Knee range of motion
6. Pain - visual analogue scale (VAS) (Revill 1976)
7. Strength
Timing of outcome measurement
Based on the distribution of data, we decided presented results at
follow-up of one year, two years and over two years (long-term
results); see Differences between protocol and review.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register (12 January 2016), the Cochrane Central
Register of Controlled Trials (CENTRAL) (the Cochrane Li-
brary 2015, Issue 12), MEDLINE (1946 to December Week
5 2015), MEDLINE In-Process & Other Non-Indexed Cita-
tions (to 11 January 2016), Embase (1980 to 2016 Week 02),
and Latin American and Caribbean Health Sciences (LILACS)
(1982 to 12 January 2016). We also searched the ISRCTN
Registry, ClinicalTrials.gov and theWHO International Clinical
Trials Registry Platform (ICTRP) (12 January 2016) for ongoing
and recently completed trials. There were no restrictions based on
language or publication status.
InMEDLINE, the sensitivity-maximising version of theCochrane
Highly Sensitive Search Strategy for identifying randomised trials (
Lefebvre 2011)was combinedwith the subject-specific search.The
search strategies for the Cochrane Library, MEDLINE, Embase,
LILACS and the trial registers are shown in Appendix 1.
Searching other resources
We checked reference lists of articles, reviews and textbooks for
possible relevant studies. Whenever necessary, we also contacted
researchers and experts in the field for unpublished studies.
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Data collection and analysis
The intended methodology for data collection and analysis was
described in our published protocol (Debieux 2012), which was
based on the Cochrane Handbook of Systematic Reviews of Interven-
tions (Higgins 2011a).
Selection of studies
Two review authors (PD and ML) independently assessed and se-
lected potentially eligible studies for inclusion in the review. Any
disagreements were resolved by discussion and, whenever neces-
sary, by discussion with a third review author (CF). The review
authors were not blinded to the journals or authors.
Data extraction and management
Two review authors (PD and ML) used a piloted data extraction
form to independently collect the data. Any disagreements were
resolved by a third review author (JB). Two review authors (PD and
ML) entered data into Review Manager. When necessary, requests
were sent to trial authors for additional information or data.
Assessment of risk of bias in included studies
Risk of bias in the included studies was independently assessed by
two review authors (ML and PD). As recommended byCochrane’s
’Risk of bias’ tool (Higgins 2011b). The following domains were
evaluated.
1. Sequence generation (selection bias).
2. Allocation concealment (selection bias)
3. Blinding of participants and personnel (performance bias)
4. Blinding of outcome assessors (ascertainment bias)
5. Incomplete outcome data (attrition bias)
6. Selective outcome reporting bias
7. Other sources of bias (including sponsorship bias and
performance bias relating to surgeon experience)
Each criterion was explicitly judged as being at either low risk of
bias, high risk of bias or unclear risk of bias (either from lack of
information or uncertainty over the potential for bias). Disagree-
ments between review authors were resolved by consensus.
Measures of treatment effect
We analysed dichotomous outcome data as risk ratios (RR) with
95% confidence intervals (CIs) and continuous outcome data as
mean differences with 95% CIs. When two or more studies pre-
sented their data derived from the same instrument of evaluation
(with the same units of measurement), we pooled data as a mean
difference (MD). Had we pooled data from studies reporting the
same variables through different instruments (and different units
of measurement), we would have used the standardised mean dif-
ference (SMD).
Unit of analysis issues
The unit of randomisation in the included trials was, as expected,
the individual participant. As none of the trials appeared to have
includedpeople undergoingbilateral ACL reconstruction, the unit
of analysis issue where data for trials were presented by knees in-
stead of individual participants did not occur. However, we were
aware of the potential for unit of analysis issues relating to outcome
reporting at different times, the use of more than one screw per
knee and for an estimate of overall treatment failure, where par-
ticipants may have had more than one complication. For the first
issue, we separately presented data at different follow-up times.
For the second issue, we checked on the descriptions given for
implant breakage and failure to see that these applied to screws or
participants. For the third issue, we performed a sensitivity anal-
ysis to check the effect of a trial that reported a large number of
intraoperative (screw breakage) complications without fully con-
firming whether these participants went on to have any further
complications.
Overall, where such unit of analysis issues arose and appropriate
corrections had not been made, we considered presenting the data
for such trials only where the disparity between the units of analysis
and randomisation was anticipated to be small.
Dealing with missing data
Wherever possible, we performed an intention-to-treat analysis
by including all randomised patients for each intervention. We
tried to contact authors of included studies in the case of missing
data such as the number of events or patients, means or standard
deviations. We did not carry out our plans to explore the effects
of missing data via worst- and best-case scenario analyses (see
Differences between protocol and review).
Assessment of heterogeneity
The heterogeneity of estimated effects in the included studies was
assessed by visual inspectionof the forest plot generated frommeta-
analysis of studies initially considered appropriate for pooling. The
degree of statistical heterogeneity was assessed based on the test for
heterogeneity and the I² statistic. If the results appeared to be very
different or the I² statisticwas greater than50%,we considered this
likely represented substantial heterogeneity. This information was
also considered with other indicators of statistical heterogeneity,
such as the chi-squared (Chi²) statistic and degrees of freedom
(df ). We assumed statistically significant heterogeneity when Chi²
exceeded df and the P value was less than 0.1.
Assessment of reporting biases
We assessed publication bias (small-study effects) by visually
checking funnel plot asymmetry in meta-analyses with more than
10 studies. This was possible for a meta-analysis of overall treat-
ment failure.
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Data synthesis
If considered appropriate, results of comparable groups of trials
were pooled. Initially, we used the fixed-effect model and 95%
confidence intervals. However, we used the random-effects model,
again with 95% confidence intervals, where substantive and un-
explained heterogeneity existed.
Subgroup analysis and investigation of heterogeneity
We planned to conduct subgroup analyses to explore different
surgical techniques (double-bundle versus single-bundle), differ-
ent graft types (patellar tendon versus hamstrings; autograft versus
allograft), different locations of interference screws (tibial versus
femoral fixation of the graft), and different classes of bioabsorbable
polymers. We would have investigated whether the results of sub-
groups were significantly different by inspecting the overlap of
confidence intervals, performing the test for subgroup differences,
and noting the I² statistic available in RevMan. However, we con-
sidered that sufficient data to accomplish these were not available.
Sensitivity analysis
Of the three pre-planned sensitivity analyses, there were sufficient
data for the outcome of overall treatment failure to investigate
the effects of allocation concealment, but not for the effects of
including studies with a high risk of bias or of missing data. We
conducted an ad hoc sensitivity analysis to check the effect of a trial
that reported a large number of intraoperative (screw breakage)
complications.
’Summary of findings’ table
We presented the main results of the bioabsorbable versus metallic
interference screws comparison in a ’Summary of findings’ table.
The ’Summary of findings’ table provides key information con-
cerning the quality of evidence, the magnitude of effect of the in-
terventions examined, and the sum of available data on the main
outcomes. We included the following primary outcomes: func-
tion using the Lysholm score (12 and 24 months) and IKDC (24
months), overall failure of treatment (intraoperative and postop-
erative complications; postoperative complications), and activity
level using Tegner score (12 and 24 months).
We used the GRADE approach to assess the quality of evidence
related to each of the above primary outcomes (section 12.2,
Higgins 2011).
R E S U L T S
Description of studies
Results of the search
The search strategy (completed January 2016) identified a to-
tal of 482 records from the following databases: Cochrane Bone,
Joint andMuscle Trauma Group Specialised Register (45 records);
CENTRAL (78),MEDLINE (117), Embase (140), LILACS (51),
ISRCTN Registry (2), ClinicalTrials.gov (20) and the WHO In-
ternational Clinical Trials Registry Platform (29). We did not ob-
tain potentially eligible studies from any other sources.
The search resulted in the identification of the citations of 42
reports of potentially eligible studies, for which full reports were
obtained where possible. We included a total of 12 studies with
data published across other publications (29 reports), published
between 1995 and 2015 (Arama 2015; Benedetto 2000; Drogset
2005; Fink 2000; Hegde 2014; Hofmann 2001; Järvelä 2008;
Kaeding 2005; Kotani 2001; Laxdal 2006; McGuire 1995; Myers
2008). Nine studies were excluded (Barber 1999; Bourke 2013;
De Wall 2011; Denti 2004; Harilainen 2009; Jagodzinski 2010;
Kocabey 2003; P omi ski 2008; Tecklenburg 2006) and three
further studies await classification (Imbert 1999; Imhoff 1997;
Toljan 1996).
A flow diagram summarising the study selection process is shown
in Figure 1.
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Figure 1. Study flowchart
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Included studies
Details of the 12 included studies can be found in the
Characteristics of included studies.
Trial reports
All 12 trials were reported in full. Seven trials were reported in
two or more publications (Arama 2015: four reports; Drogset
2005: three reports; Fink 2000: two reports;Hofmann 2001: three
reports; Järvelä 2008: five reports; Laxdal 2006: three reports;
McGuire 1995: four reports). Single reports were available for the
other five trials (Benedetto 2000; Hegde 2014; Kaeding 2005;
Kotani 2001; Myers 2008). The origins of the outcome data used
in this review for each of the seven trials with several publica-
tions are noted in the Characteristics of included studies. No new
data were presented in the conference abstracts available for five
trials (Arama 2015; Hofmann 2001; Järvelä 2008; Laxdal 2006;
McGuire 1995).
Arama2015,which included40participants, was reported in three
conference abstracts, the first being a presentation at the AAOS
annual meeting in 2007 (Pinczewski 2007). Two subsequent ab-
stracts were published in 2012 (Pinczewski 2012a; Pinczewski
2012b), both reporting five years of follow-up. Finally, the main
article was published in 2015 (Arama 2015), also with five years
of follow-up.
For McGuire 1995, trial participants initially reported in the first
report (McGuire 1995a) were subsequently described in three
other publications. This multicentre randomised trial included
several types of graft (patellar tendon, hamstrings, and allograft)
and additional fixation devices that were selected for use. Of the
204 patients enrolled in the trial, 117 had reconstruction with a
patellar tendon autograft (McGuire 1995a). There were two re-
portswhich startedwith a baseline of 114participants who hadun-
dergone ACL reconstruction with patellar tendon (Barber 1995;
Barber 2000). Barber 1995 reported on the outcome of 85 partici-
pants at aminimumof 12-month follow-up. Barber 2000 reported
on 68 participants who had reached the minimum of 24-month
follow-up. We chose to use data from the two reports of this sub-
group (Barber 1995; Barber 2000) since the complete data are not
available for the full population and this also avoids confounding
where different grafts were usedMcGuire 1995a; McGuire 1999).
Drogset 2005 first reported on the outcome of 41 participants
with two-year follow-up. With the exception of two participants
in the bioabsorbable group who were excluded due to re-rupture,
the outcome of the same participants was reported at seven years
follow-up (Drogset 2011). Another article on the trial popula-
tion reported on inflammatory mediators (C5a, TCC, and IL-8)
(Drogset 2006).
Fink 2000 was reported in both English (Fink 2000) and German
(Hackl 2000) publications. Both reports described the same pop-
ulation, methods and outcomes.
Hofmann 2001 was originally published as abstract in German
(Wagner 1999). Full reports were subsequently published in Ger-
man (Sudkamp 2000) and then in English (Hofmann 2001).
As explained in the Characteristics of included studies entry for
Järvelä 2008, there are several publications for this trial, which
compared three interventions: single-bundle reconstruction and
fixation with a bioabsorbable interference screw; single-bundle re-
construction and fixation with a metallic interference screw; and
double-bundle reconstruction and fixation with a bioabsorbable
interference screw. In this review, we used data from 52 partici-
pants in the first two groups in the main report published in 2008
(Järvelä 2008a); and from another report of 62 participants of the
first two groups published in the same year (Moisala 2008).
There are three reports for Laxdal 2006, which was published with
the initial two-year follow-up in 2006. Follow-up at an average of
eight years was reported at a meeting in 2009 (Stener 2009) and
in an article in 2010 (Stener 2010).
Design
Eleven studies were randomised controlled trials (RCTs) and one
was a quasi-randomised trial (Kaeding 2005).
Setting
Eleven studies were conducted in nine individual countries: Aus-
tralia (two), Austria (one), Finland (one), Germany (one), Índia
(one), Japan (one), Norway (one), Sweden (one) and USA (two).
The remaining study (Benedetto 2000) was performed in two
countries (Austria and the Netherlands).
Sample sizes
The included studies enrolled a total of 944 participants. The
sample sizes ranged from 24 participants in Hegde 2014 to 204
participants in McGuire 1995. Outcome data were available for a
total of 774 participants (82%).
Participants
Regarding gender, 574 participants were male and the gender of
14 participants was not specified. Nine studies limited the age of
the participants. Two studies limited the age of the participants to
over 16 years (Laxdal 2006;McGuire 1995), one study limited the
age of the participants to between 15 and 50 years old (Benedetto
2000) and four studies were limited to participants with closed
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physis (Fink 2000; Järvelä 2008; Kaeding 2005; Myers 2008).
One study (Hegde 2014) was limited to patients between 20 and
60 years old.
Interventions
Of the 944 participants (774 assessed) for whom allocation was
known, 471 were assigned to the bioabsorbable interference screw
group (394 assessed) and 459 were assigned to the metallic screw
group (380 assessed). The interventions, site or sites of randomi-
sation (i.e. femur or tibia), graft used and other details of the ACL
reconstruction are summarised in Table 1 and below. All opera-
tions involved single-bundle ACL reconstruction.
Regarding the type of bioabsorbable screws, six studies used poly-
L-lactic acid (PLLA) (Drogset 2005; Hofmann 2001; Kaeding
2005; Kotani 2001; Laxdal 2006; McGuire 1995), two used
copolymer of polyglycolic acid (PGA) and the elastomer trimethy-
lene carbonate (PGA-TMC) (Benedetto 2000; Fink 2000), one
study used copolymers composed of L-lactide, D-lactide, and
trimethylene carbonate (PLLA-TMC-PDLA) (Järvelä 2008) and
two used PLLA with hydroxyapatite (PLLA-HA) (Arama 2015;
Myers 2008).One study did not describe the type of bioabsorbable
screws used (Hegde 2014). Regarding the type of metallic screws,
10 used titanium and two (Järvelä 2008; Hegde 2014) did not
mention the type of screw used.
Seven studies used the patellar tendon grafts (Benedetto 2000;
Drogset 2005; Fink 2000; Hofmann 2001; Kaeding 2005; Kotani
2001; McGuire 1995) and five used hamstring tendons (Arama
2015; Hegde 2014; Järvelä 2008; Laxdal 2006; Myers 2008).
Seven studies randomised the types of screws both in the femur and
tibia (Arama 2015; Järvelä 2008; Hofmann 2001; Kaeding 2005;
Laxdal 2006; McGuire 1995; Myers 2008) and three (Benedetto
2000; Drogset 2005; Fink 2000) randomised screw types only
in the femur. One study randomised the screw only in the tibia
(Hegde 2014) and one did not mention where the randomised
screwwas used (Kotani 2001).OnlyBenedetto 2000 andMcGuire
1995 used an additional tibial fixation method (staples or screws
with washers) other than interference screws.
Outcome measures
The studies varied in timing of follow-up. Two studies (Benedetto
2000; Hegde 2014) specified follow-up at one year; six studies
(Drogset 2005; Fink 2000;Hofmann 2001; Järvelä 2008; Kaeding
2005;McGuire 1995) specified follow-up time points betweenone
and two years; and three studies (Kotani 2001; Laxdal 2006;Myers
2008) specified follow-up at two years. Three studies (Arama2015;
Drogset 2005; Laxdal 2006) reported extended follow-up of five
years or more.
Primary outcomes
Subjectively-rated knee function
Eight studies reported the Lysholm Knee Score (Arama 2015;
Drogset 2005; Fink 2000;Hegde 2014; Järvelä2008; Laxdal 2006;
Myers 2008;McGuire 1995).Drogset 2005 also reported theKnee
Injury & Osteoarthritis Outcome Score (KOOS). Drogset 2005
presented data for both outcomes in graphical form only. Kotani
2001 assessed function and quality of life with two non-validated
scores. The first was the ability to sit in the Japanese style and the
second was the Japanese Orthopaedic Association (JOA) score.
Five studies used various versions of the International Knee Doc-
umentation Committee (IKDC) score to report on subjectively-
rated knee function (Arama 2015; Benedetto 2000; Hofmann
2001; Järvelä 2008; Kaeding 2005). In Drogset 2005, participants
rated their knee function according to four categories: excellent,
good, fair or poor.
Treatment failure and adverse events
All studies reported on individual adverse events, to various ex-
tents, with the exception of Hegde 2014. Seven studies reported
on implant failure or breakage (Arama 2015; Benedetto 2000;
Hofmann 2001; Kaeding 2005; Kotani 2001; McGuire 1995;
Myers 2008). Eight studies reported on infection (Arama 2015;
Benedetto 2000; Drogset 2005; Fink 2000; Hofmann 2001;
Kaeding 2005; Laxdal 2006; McGuire 1995). Eight studies re-
ported graft failure or rupture (Arama 2015; Benedetto 2000;
Drogset 2005; Fink 2000; Järvelä 2008; Laxdal 2006; McGuire
1995; Myers 2008). One study reported on graft damage dur-
ing screw insertion (Benedetto 2000). Three studies reported
on symptomatic foreign body reactions (Benedetto 2000; Kotani
2001; McGuire 1995). Six studies reported on effusion (Arama
2015; Benedetto 2000; Drogset 2005; Hofmann 2001; Kaeding
2005; McGuire 1995). Three studies reported on arthrofibrosis
and surgery for cyclops lesions and adhesions (Benedetto 2000;
Kotani 2001; McGuire 1995). Various other adverse events were
listed in several studies, in particular for McGuire 1995, which
provided a detailed summary in the text of the postoperative com-
plications that were “reported to the Food and Drug Adminis-
tration (FDA) under the requirements of the investigative device
exemption (IDE) protocol”.
Activity level
Five studies assessed Tegner activity level (Drogset 2005; Fink
2000; Hegde 2014; Laxdal 2006; McGuire 1995). Drogset 2005
presented data in graphical form only. Hofmann 2001 reported
activity level as “the same as before”, “increased,” or “decreased”.
Kaeding 2005 assessed this outcome as “strenuous, moderate,
light, and sedentary activity levels”.
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Secondary outcomes
Clinician-rated scores
Six studies reported results from the clinical knee examination
aspect of the International Knee Documentation Committee
(IKDC) score (Arama 2015; Benedetto 2000; Fink 2000; Järvelä
2008; Laxdal 2006; Myers 2008).
General quality of life general health measures
None of the studies reported these outcomes.
Objective function tests
The single-leg hop test, reported in Arama 2015 and Laxdal 2006,
was the only functional test reported by any study in this review.
Knee laxity and stability
Nine studies evaluated knee laxity with the KT-1000 knee
arthrometer (Arama 2015; Benedetto 2000; Drogset 2005; Fink
2000; Järvelä 2008; Kaeding 2005; Kotani 2001; Laxdal 2006;
McGuire 1995), while Myers 2008 used a Rolimeter.
Knee stability was assessed via the Lachman test in six studies
(Arama 2015; Benedetto 2000; Drogset 2005; Hofmann 2001;
Kotani 2001; McGuire 1995) and via the pivot-shift test in seven
studies (Arama 2015; Benedetto 2000; Drogset 2005; Järvelä
2008; Kotani 2001; McGuire 1995; Myers 2008).
Kotani 2001 also reported on the results of the anterior drawer
stress test. Hofmann 2001 reported on the subjectively-rated sta-
bility and Kaeding 2005 on “giving way” (extreme, moderate, ab-
sent).
Knee range of motion
Hofmann 2001 and Kaeding 2005 presented continuous range
of motion data for flexion and extension. Six studies (Arama
2015; Benedetto 2000; Drogset 2005; Kotani 2001; Laxdal 2006;
McGuire 1995) presented numbers of participants with range of
movement deficits or complications relating to loss of range of
motion.
Pain
Three studies assessed pain as an outcome. Kaeding 2005 accessed
pain during strenuous, moderate or sedentary activity at 12 and
24months of follow-up. Benedetto 2000 reported persistent pain-
related complications at 12months follow-up andHofmann 2001
reported on pain at 24 months follow-up.
Excluded studies
We excluded nine studies. Five were excluded as they did
not compare bioabsorbable versus metallic interference screws
(Bourke 2013; DeWall 2011; Harilainen 2009; Jagodzinski 2010;
Tecklenburg 2006). Two were excluded because they were not
randomised or quasi-randomised trials (Denti 2004; P omi ski
2008). We also excluded Barber 1999 because it mainly re-
ported on a histological study involving sheep and Kocabey 2003,
which was a cadaveric study. Further details are provided in
Characteristics of excluded studies.
Studies awaiting classification
Three studies are awaiting classification (Imbert 1999; Imhoff
1997; Toljan 1996). An inclusion or exclusion decision could
not be made for these studies because insufficient information
was available. Attempts were made to contact these authors
but no responses were received. Further details are provided in
Characteristics of studies awaiting classification.
Ongoing study
We did not identify any ongoing studies that addressed the com-
parison.
Risk of bias in included studies
Summaries of our assessments are presented in Figure 2 and Figure
3.
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Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Kaeding 2005 was quasi-randomised trial that used the last num-
ber of the patient’s hospital ID; we judged this trial as having a
high risk of selection bias relating to sequence generation and lack
of allocation concealment. Both Arama 2015 and McGuire 1995
reported computer-based randomisation and were judged at low
risk for bias relating to sequence generation. As none of the other
nine included studies described their method of random sequence
generation, each was assessed as at unclear risk of bias for this
domain. Of the seven studies using sealed envelopes, five were
assessed as having low risk of bias as they gave sufficient details
that assured there was adequate allocation concealment (Arama
2015; Benedetto 2000; Fink 2000; McGuire 1995; Myers 2008).
The other two studies (Järvelä 2008; Laxdal 2006), together with
Drogset 2005, which referred to the “envelope method” without
further details, were assessed at unclear risk of bias because they
did not mention safeguards to ensure allocation concealment. The
other three studies that reported use of randomisation without
describing their methods were also rated as at unclear risk of bias
(Hegde 2014; Hofmann 2001; Kotani 2001).
Blinding
Blinding of surgeons performing the operation was not possible
and so all trials were assessed at high risk of performance bias. We
classified the four studies that reported that blinding of outcome
assessment as having a low risk of detection bias (Arama 2015;
Järvelä 2008; Laxdal 2006; Myers 2008). We classified the seven
studies that did not describe whether outcome assessments were
blinded as having an unclear risk of detection bias (Benedetto
2000; Fink 2000; Hegde 2014; Hofmann 2001; Kaeding 2005;
Kotani 2001; McGuire 1995). One study (Drogset 2005) did not
blind outcome assessment and was classified as having high risk of
detection bias.
Incomplete outcome data
Three studies (Benedetto 2000; Kaeding 2005; McGuire 1995)
had excessive unexplained losses during follow-up. Järvelä 2008
had variable losses according to different publications; these were
only partially explained. Laxdal 2006 and Myers 2008 had post-
randomisation exclusions for which the reasons for exclusion were
not completely explained. These six studies were assessed as having
high risk of attrition bias.
It was not clear whether all randomised participants had been
accounted for in Arama 2015 or Kotani 2001. This trial as well
as Drogset 2005, which had a small imbalances in loss to follow-
up, was assessed as having an unclear risk of attrition bias. The
studies that showed no, minimal or justified losses (Fink 2000;
Hegde 2014; Hofmann 2001) were assessed as having a low risk
of attrition bias.
Selective reporting
Three studies presented appropriate outcomes, specifically includ-
ing what our specified primary outcomes (Arama 2015; Drogset
2005; Fink 2000). Two were assessed as having a low risk of re-
porting bias (Drogset 2005; Fink 2000), but Arama 2015 was as-
sessed at unclear risk given the failure to report outcome at two-
year follow-up. McGuire 1995 was assessed as having a high risk
of selective reporting bias given the reporting of interim results
for different populations. Studies that did not present the primary
outcomes, instead reporting other outcomes we considered were
less relevant, were also classified as having high risk of report-
ing bias (Benedetto 2000; Hegde 2014; Kaeding 2005; Kotani
2001; Laxdal 2006; Myers 2008). Studies that reported primary
outcomes in a partial way or using non-validated questionnaires
were assessed as having an unclear risk of reporting bias (Hofmann
2001; Järvelä 2008). Additionally, we considered that the report-
ing in several publications of different outcomes for different sized
populations at different follow-up times put Järvelä 2008 at high
risk of selective reporting bias.
Other potential sources of bias
Benedetto 2000, Myers 2008 and Arama 2015 received funds
from Smith & Nephew Inc., which we assessed as putting them
at high risk of sponsorship bias. Kotani 2001 did not completely
describe their methods and results and did not respond to our
attempt to contact the authors. This study was thus assessed as
having a high risk of bias. Five studies (Drogset 2005; Fink 2000;
Hegde 2014; Hofmann 2001; Kaeding 2005) appeared to be free
of other sources of bias. It was unclear whether the remaining
studies (Järvelä 2008; Laxdal 2006; McGuire 1995) were at risk
of other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison
Bioabsorbable versus metallic interference screws for graft fixation
in anterior cruciate ligament reconstruction
All 12 included studies reported on the comparison that is the focus
of this review: bioabsorbable versus metallic interference screw
for graft fixation in ACL reconstruction. None of the planned
subgroup analyses were undertaken because of insufficient data.
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Bioabsorbable versus metallic interference screws
Primary outcomes
Knee function
Lysholm knee score (0 to 100; higher scores = better outcome)
None of the eight trials recording the Lysholm knee score re-
ported a statistically significant or clinically important difference
between the two groups at follow-up (Arama 2015; Drogset 2005;
Fink 2000; Hegde 2014; Järvelä 2008; Laxdal 2006; Myers 2008;
McGuire 1995). The available data from five trials are presented
at three follow-up times in Figure 4 (Analysis 1.1). The data for
McGuire 1995 are from the subgroup of participants who had
patellar tendon graft reconstruction. Pooled data showed minimal
differences between the two groups in the Lysholm scores at 12
months (mean difference (MD) -0.08, 95% confidence interval
(CI) -1.48 to 1.32; three trials, 168 participants), at 24 months
(MD 0.35, 95% CI -1.27 to 1.98; three trials, 113 participants)
or at five years or more follow-up (MD 1.23, 95% CI -2.00 to
4.47; two trials, 71 participants).
Figure 4. Forest plot: 1.1 Function (Lysholm knee score: 0 to 100; higher scores = better function).
Hegde 2014 (24 participants) reported mean Lysholm scores at
one-year follow-up of 84.33 in the bioabsorbable screw group and
83.67 in the metallic screw group. Laxdal 2006 reported there
were no statistically significant differences between the two groups
in the median Lysholm scores at either 24 months (90 versus 94;
68 participants) or at eight years follow-up (90 versus 89; 64 par-
ticipants). Myers 2008 (100 participants) reported mean Lysholm
scores at two years follow-up of 91.7 in the bioabsorbable screw
group and 90.5 in the metallic screw group. These studies could
not be pooled due to lack of available data even after attempting
to contact authors.
Other self-reported function scores
Drogset 2005 (34 participants) found no difference in the Knee
Injury & Osteoarthritis Outcome Score (KOOS) results at the
seven-year follow-up; this was consistent with lack of between-
group differences shown graphically for the five subscales of the
KOOS score (pain; symptoms; activities of daily living, sports,
quality of life).
Although Kaeding 2005 appears to have used the subjective eval-
uation of knee function using the International Knee Documen-
tation Committee (IKDC) questionnaire, there was no report of
this outcome at either one- or two-year follow-up. Järvelä 2008
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presented the results of the part of subjective questionnaire that
rated knee function in terms of limitations in activities of daily liv-
ing (score 0 to 10; higher values = better function). They found no
difference between the two groups at one- or two-year follow-up
(two years: mean (SD): 9 (1) versus 9 (2); 41 participants; reported
P = 0.821). Two trials reported categorical data for subjective as-
sessment of knee function derived from the IKDC knee examina-
tion score (Benedetto 2000; Hofmann 2001) and two other trials
reported on knee function based on four categories (Benedetto
2000; Drogset 2005). None of these four studies reported a differ-
ence between the two groups in acceptable knee function (rated in
different ways) at the various follow-up times (e.g. 12 months: 76/
80 versus 67/69; risk ratio (RR) 0.98, 95% CI 0.91 to 1.05; two
trials; Analysis 1.2). Arama 2015 reported no difference between
groups in subjective IKDC (0 to 100: no limitations) results at
five years: bioabsorbable mean 93 (SD 11.4) versus metallic mean
93 (SD 7.0); 37 participants.
Kotani 2001 assessed function by two non-validated scores; al-
though slightly favouring the metallic screw group, there was no
significant between-groups differences at an average of 21 months
in the inability to sit in the Japanese style (8/46 versus 5/45; RR
1.57, 95% CI 0.55 to 4.42) or in the Japanese Orthopaedic As-
sociation (JOA) score (0 to 100: higher scores = better outcome):
MD -5.70, 95% CI -25.16 to 13.76; not shown in the analyses.
Treatment failure and adverse events
For these outcomes, we used the complete series of McGuire
1995. In interpreting the detailed list of complications provided
in McGuire 1995, we extracted only those that came under our
chosen categories and excluded those that appeared unrelated to
the allocation of screw type. Examples of the latter are compli-
cations relating to meniscal repair and traumatic re-injuries, such
as patellar fracture, that were not related to the ACL graft. Myers
2008 excluded four participants who had complications (implant
breakage, graft re-rupture and persistent effusion). We have in-
cluded data for the three participants for whom treatment alloca-
tion was known. Although we considered secondary procedures
and surgery in our interpretation of complications, we did not
present data for re-operations as these were incomplete.
Overall treatment failure and adverse events
To assess overall treatment failure, we summed data for implant
breakage during surgery and major postoperative complications
(implant failure, graft rupture, symptomatic foreign body reac-
tions, effusion and treated arthrofibrosis and related conditions)
that were usually described in the trial reports as requiring fur-
ther substantive treatment. Pooled results for the 11 trials report-
ing on complications are shown in Analysis 1.3 (Figure 5). This
shows there were twice as many treatment failures in the bioab-
sorbable screw group (60/451 versus 29/434; RR 1.94, 95% CI
1.29 to 2.93; P = 0.001). Given that these results are dominated
by McGuire 1995, for which there is some uncertainty in terms
of unit of analysis issues and a high intraoperative screw breakage,
we performed a sensitivity analysis removing McGuire 1995. The
overall result still favoured themetallic screw group (38/348 versus
20/333; RR 1.76, 95% CI 1.07 to 2.89). Another sensitivity anal-
ysis was to include only the five trials with low risk of bias related
to allocation concealment; this again provided a result favouring
metallic screws: 34/260 versus 18/247; 95% CI 1.73, 95% CI
1.03 to 2.93). An analysis of postoperative treatment failure also
showed greater failure in the bioabsorbable screw group (44/451
versus 29/434; RR 1.44, 95%CI 0.93 to 2.23; P = 0.10); however,
since the 95% CI crosses the line of no effect, these results include
the possibility of a higher failure rate in the metallic group.
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Figure 5. Forest plot: Overall treatment failure.
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A funnel plot analysis of intra- and postoperative treatment fail-
ure does not show asymmetry or suggest the possibility of major
publication bias reflecting systematic differences between smaller
and larger studies (‘small-study effects’) (Figure 6).
Figure 6. Funnel plot for outcome: Overall treatment failure (intra- and post-operative complications)
The results for individual complications are presented in Analysis
1.4. Only the pooled results for implant failure or breakage were
statistically significant, thus meeting the P < 0.05 criterion. The
incidences of graft rupture and joint effusion were higher in the
bioabsorbable screw group but the results for both complications
were not statistically significant and the converse finding in favour
of the bioabsorbable screw are also possible.
Implant failure or breakage
This outcome applied almost exclusively to the breakage of bioab-
sorbable screws during surgery. Three of the six studies report-
ing this outcome stated that no breakage occurred (Arama 2015;
Benedetto 2000; Kaeding 2005). Pooled results from seven trials
show significantly greater implant failure occurred in the bioab-
sorbable screw group (16/351 versus 1/338; RR 6.88, 95% CI
1.85 to 25.56; P = 0.004; see Analysis 1.4). The evidence was
dominated byMcGuire 1995, which reported 12 instances of bro-
ken bioabsorbable (PLLA) screws during insertion and one metal
screw that loosened and required removal. Of the 12 broken PLLA
screws, the screw was left in situ in five cases, was replaced by an-
other PLLA screw in five cases and supplemented by a metal screw
in the other two cases. A report of the subgroup of participants
which received a patella tendon graft, stated that all six broken
screws for this subgroup were 7 mm diameter screws inserted into
the femoral site (Barber 1995). Thus we have assumed that the 12
cases of broken screw applied to individual participants given that
one screw was used for this location. Barber 1995 reported that
the 7 mm screw was modified and a 8 mm screw made available
subsequent to the conclusion of their study.
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Infection
Pooled data from the eight studies reporting on infection did not
reveal a difference between the two screw types (6/316 versus 6/
288; RR 0.92, 95% CI 0.36 to 2.36; see Analysis 1.4).
Graft rupture
Pooled results from the eight studies reporting graft failure or
rupture showed a higher incidence in the bioabsorbable screw
group (12/332 versus 6/299; RR 1.70, 95% CI 0.69 to 4.19; P
= 0.25; see Analysis 1.4). However, the 95% confidence interval
crosses the line of no effect and thus includes the possibility of a
higher graft rupture rate in the metallic group. Where details were
given, all ruptures resulted from a re-injury except for a partial tear
described in Benedetto 2000.
Symptomatic foreign body reactions
Three studies (Benedetto 2000; Kotani 2001; McGuire 1995)
specifically referred to symptomatic foreign body reactions as an
outcome. The only case, which involved a soft fluid-filled subcu-
taneous cyst, was reported in Benedetto 2000 (1/197 versus 0/
172; RR 2.52, 95% CI 0.10 to 60.67; see Analysis 1.4).
Effusion
Pooled results from six studies (Arama 2015; Benedetto 2000;
Drogset 2005; Hofmann 2001; Kaeding 2005; McGuire 1995)
showed greater incidence of, usually treated, joint effusion in the
bioabsorbable screw group (18/255 versus 11/234; RR 1.54, 95%
CI 0.76 to 3.11; P = 0.23; see Analysis 1.4). However, the 95%
confidence interval crosses the line of no effect and thus includes
the possibility of a higher rate of effusion in the metallic group.
The data for three trials (Benedetto 2000; Kaeding 2005;McGuire
1995) apply to 12 months follow-up, those for Drogset 2005 and
Hofmann 2001 apply to 24months follow-up and those (all ’mild’)
for Arama 2015 apply to five years follow-up.
Arthrofibrosis, cyclops lesions and adhesions
Pooled data from three studies reporting on arthrofibrosis and
surgery for cyclops lesions and adhesions did not show a difference
between the two groups (10/202 versus 11/177; RR 0.79, 95%
CI 0.34 to 1.82; see Analysis 1.4).
Graft damage (during surgery)
Benedetto 2000 reported on four cases of slight damage to the
graft during insertion of screws (3/67 versus 1/57) as well as slight
damage to the medial femoral condyle by drilling for two partici-
pants in the bioabsorbable screw group. The clinical implications
of this structural damage are unclear.
Activity level
This was reported in terms of the Tegner activity score in five trials
(Drogset 2005; Fink 2000; Hegde 2014; Laxdal 2006; McGuire
1995), in terms of previous activity level in Hofmann 2001 at
12 and 24 months follow-up, and category of activity level at 12
months in Kaeding 2005.
Tegner activity score (0 to 10: higher scores = better activity)
The available data from two of the five trials reporting Tegner
scores are presented at two follow-up times in Analysis 1.5. The
data for McGuire 1995 are from the subgroup of participants who
had patellar tendon graft reconstruction. Pooled data showedmin-
imal differences between the two groups in the Tegner scores at
12 months (MD 0.08, 95% CI -0.39 to 0.55; 2 trials, 122 par-
ticipants) and at 24 months follow-up (MD 0.01, 95% CI -0.54
to 0.57; 2 trials, 72 participants). The two-year follow-up data for
36 participants fromMcGuire 1995 are from a preliminary report
(Barber 1995); a later report including 68 participants reported
much lower but still similar scores for the two groups: 3.97 versus
3.88.Graphs presented forDrogset 2005 (34 participants) showed
higher Tegner scores in the metallic screw group at 12 and 24
months and seven years follow-up; the between-group difference
at two years was reported to be statistically significant (reported
P < 0.05). Reading the values from the graph indicates a mean
difference of just over 1.0 at this follow-up time. Hegde 2014 (24
participants) reported mean Tegner scores at one-year follow-up
of 6.50 in the bioabsorbable screw group and 6.67 in the metallic
screw group. Laxdal 2006 reported there was no statistically sig-
nificant differences between the two groups in the median Tegner
scores at either 24 months (7 versus 6; 68 participants) or at eight
years follow-up (7 versus 6; 64 participants).
Other measures of activity
Hofmann 2001 (30 participants), which assessed subjectively-
rated activity level as ’as before’, ’increased’, or ’decreased’ relative
to preoperative level found no difference between the two groups
in those with decreased activity at one- and two-year follow-up
(Analysis 1.6). Kaeding 2005 found no difference between the two
groups in the distribution of activity level (strenuous, moderate,
light and sedentary) at one year (97 participants) but reported a
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significant difference (reported P = 0.015) in favour of the bioab-
sorbable screw group at two years. While fewer participants in the
bioabsorbable group only participated in light or sedentary activ-
ities (5/31 versus 12/31; RR 0.46, 95% CI 0.18 to 1.15; Analysis
1.6), these data are at high risk of attrition bias given the substan-
tial follow-up losses (33%).
Secondary outcomes
Clinician-rated scores
International Knee Documentation Committee (IKDC)
Six studies reported on the knee function results based on the
primarily objective part of the International Knee Documenta-
tion Committee form (Arama 2015; Benedetto 2000; Fink 2000;
Järvelä 2008; Laxdal 2006; Myers 2008). Of the five studies re-
porting knee function results based on the primarily objective part
of the International Knee Documentation Committee form, only
Myers 2008 reported on the scores. Myers 2008 found very similar
IKDC objective scores (0 to 100: higher scores = better result) in
the two groups at two years (mean 87.5 versus 85.2; 100 partici-
pants).
The other five studies presented their results by according to
four categories (A (normal), B (nearly normal), C (abnormal), D
(severely abnormal)). The available results at 12, 24 months and
over five years of follow-up for the numbers of participants whose
knees were rated ’normal’ or ’nearly normal’ are presented in Anal-
ysis 1.7. At 12 and 24 months of follow-up, there was little differ-
ence between the two groups (12 months: 80/85 versus 69/75; RR
1.03, 95% CI 0.94 to 1.12; two trials; 24 months: 62/74 versus
55/71; RR 1.09, 95% CI 0.93 to 1.27; three trials). All knees fol-
lowed up at five years in Arama 2015 had normal or nearly normal
results.
Objective function tests
Although Laxdal 2006 reported a significant difference (P = 0.007)
at 24 months in favour of the bioabsorbable screw for the single-
leg hop test, this was not reflected in the data (see Analysis 1.8).
There was also no between-group difference at eight years follow-
up (median % of non-injured side was 96 in both groups). At
five years follow-up, Arama 2015 found no difference between the
two groups in the number with 90% or greater performance of
the single-leg hop test (see Analysis 1.8); all five participants with
impaired performance had between 76% to 89% performance
compared with the uninvolved limb.
Knee laxity and stability
Instrumental measurement of knee laxity
None of the nine studies evaluating knee laxity with the KT-1000
knee arthrometer found a difference between the two screw types
at the follow-up times reported by each trial. The available contin-
uous outcome data from eight trials are presented at four follow-
up times in Analysis 1.9. The data for McGuire 1995 are from the
subgroup of participants who had patellar tendon graft reconstruc-
tion. The pooled data showed minimal differences between the
two groups at six months (MD -0.07 mm, 95% CI -0.53 to 0.39;
83 participants, two trials); 12 months (MD 0.06 mm, 95% CI
-0.12 to 0.24; 473 participants, six trials); 24 months (MD 0.05
mm, 95% CI -0.39 to 0.49; 178 participants, four trials) or five
or more years follow-up (MD -0.48 mm, 95% CI -1.39 to 0.42;
68 participants, two trials). Laxdal 2006 reported no significant
between-group differences at 24 months (median 0.75 mm versus
1.5 mm; 68 participants) or at eight years follow-up (median 1.0
mm in both groups; 64 participants).
Based on a threshold of 3 mm or greater displacement measured
with the KT-1000 knee arthrometer in three trials (Benedetto
2000; Drogset 2005; McGuire 1995) and the Rolimeter in Myers
2008, binary data from four trials (321 participants) at 12months,
three trials (173 participants) at 24 months and one trial (31 par-
ticipants) at seven years shownodifference between the two groups
in the numbers of participants with knee instability (see Analysis
1.10).
Lachman test (positive for knee instability)
Studies evaluating knee laxity with the Lachman test (Arama
2015; Drogset 2005; Hofmann 2001; Kotani 2001; McGuire
1995) showed no significant differences between the screw types
at 12 months (two trials), 24 months (29/112 versus 30/112; RR
0.97, 95% CI 0.64 to 1.49; 224 participants, four trials) or five or
more years (13/33 versus 14/35; RR 0.99, 95% CI 0.56 to 1.73;
68 participants, two trials); see Analysis 1.10).
Pivot-shift test (positive for knee instability)
Studies evaluating knee laxity with the pivot-shift test (Arama
2015; Drogset 2005; Hofmann 2001; Kotani 2001; McGuire
1995; Myers 2008) showed no significant differences between the
screw types at 12 months (29/195 versus 26/182; RR 1.08, 95%
CI 0.67 to 1.73; five trials) or at 24 months (34/168 versus 29/
167; RR 1.16, 95% CI 0.75 to 1.80, five trials); see Analysis 1.10).
Although Drogset 2005 found fewer participants in the bioab-
sorbable group had a positive pivot-shift test at seven years (1/15
versus 5/16; RR 0.15, 95%CI 0.02 to 1.10), this result contrasted
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to findings of a lack of differences for the Lachman test and in-
strumental laxity at seven years for the same population. Pooled
data from Arama 2015 and Drogset 2005 for five or more years
of follow-up also showed fewer participants in the bioabsorbable
group with a positive pivot-shift test (4/33 versus 11/35; RR 0.39,
95% CI 0.13 to 1.11; two trials; P = 0.08).
Subjective reports of knee instability
Both Hofmann 2001 (30 participants) and Kaeding 2005 (65
participants at two years) found similar results in the twogroups for
subjective reports of instability (“giving way”) (data not presented
in review).
Knee range of motion
Hofmann 2001 (30 participants) reported no significant between-
group differences at two years in mean flexion (95 versus 105
degrees) andmean extension (6 versus 4 degrees). Two-year follow-
up results from Kaeding 2005 for ’flexion limit’ and ’extension
limit’ also showed no clinically relevant differences between the
two groups (Analysis 1.11).
Pooled data from six studies of the number of participants with
range of motion deficits show little difference between the two
groups (37/218 versus 28/203; RR 1.18, 95% CI 0.83 to 1.67;
Analysis 1.12). Both participants in Arama 2015 with range of
motion deficients had extension deficits of between 3º to 5º at five
years follow-up. Two studies reported range of motion deficits as
complications: Benedetto 2000 reported seven participants with
poor range of motion, six of whom received subsequent surgery,
and all four participants listed for Kotani 2001 had arthrofibrosis.
At two years, seven participants in Drogset 2005 had extension
deficits between 5 to 10 degrees; no participant had any deficit
at seven years follow-up. Laxdal 2006 found no difference at two
years between the two groups in the numbers with flexion deficits
of at least 5 degrees, nor for extension deficits (8/33 versus 5/28).
Very few participants of McGuire 1995 had either a flexion or
an extension deficit. We present the data for participants with a
flexion deficit (flexion < 120 degrees) at two years for the subgroup
given patellar tendon grafts reported in Barber 2000.
Pain
Three studies reported separate data for long-termpain (Benedetto
2000; Hofmann 2001; Kaeding 2005). Benedetto 2000 reported
on complications relating to knee pain at specific sites in the knee
at 12 months. Hofmann 2001 reported participants with either
mild or significant knee pain at 24 months. Pooled data showed
no difference between the two groups (4/77 versus 3/67; RR 0.94,
95% CI 0.26 to 3.41; Analysis 1.13). Kaeding 2005 presented
percentages of participants in the two groups who had pain during
strenuous, moderate or sedentary activity at 12 and 24 months.
Although the percentages added up to 100% in each case, the
actual denominators were missing. Kaeding 2005 reported that
pain with activity was significantly greater (P < 0.05) in the bioab-
sorbable group different at one-year follow-up (97 participants)
but similar in the two groups at two years (65 participants); it is
likely that there was one participant in each group who had pain
during sedentary activities at this time.
Sensitivity analysis
Sensitivity analysis was performed for the outcome: treatment fail-
ure. More specifically, it was conducted for the outcome “intraop-
erative screw breakage”, since McGuire 1995 disproportionately
impacts the results by the number of events. Therefore, we ex-
cluded this study and re-calculated the results, noting that there
was no change in the direction of the results (38/346 versus 20/
332; RR 1.86, 95% CI 1.12 to 3.11).
D I S C U S S I O N
Summary of main results
This review analysed the results of 12 trials (11 randomised andone
quasi-randomised clinical trials). The studies randomised a total
of 944 participants and reported follow-up results for 774 partic-
ipants. Participants underwent anterior cruciate ligament (ACL)
reconstruction with either hamstring tendon grafts (five trials) or
patellar tendon grafts (seven trials). Trials participants were ran-
domly allocated to bioabsorbable or metallic interference screws
for graft fixation in both femur and tibia (seven trials); femur only
(three trials); tibia only (one trial); location was not reported in
the remaining trial.
Themain results of the comparison of bioabsorbable versus metal-
lic interference screw fixation for graft fixation in ACL recon-
struction are presented in Summary of findings for the main
comparison. These show a consistent picture, albeit supported by
very low-quality evidence, of no clinically important differences be-
tween the two types of screws in self-reported knee function, mea-
sured using the Lysholm knee score, at one, two or five or more
years follow-up. Treatment failure was represented by the summed
data for implant breakage during surgery and major postoperative
complications (implant failure, graft rupture, symptomatic for-
eign body reactions, knee effusion and treated arthrofibrosis and
related conditions) that were usually described in the trial reports
as requiring further substantive treatment. There is very low-qual-
ity evidence that in a population with an assumed risk (based on
the median control group risk) of 56 participants per 1000 having
treatment failure after metallic screw fixation, 53 more (95% CI
17 to 108 more) participants had treatment failure after bioab-
sorbable screw fixation. All 16 intraoperative complications in the
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bioabsorbable screw group were implant breakages upon screw in-
sertion. Treatment failure defined as postoperative complications
only, still favoured the metallic screw group but the 95% CI also
included the potential for a greater risk of treatment failure after
metallic screw fixation. Based on the assumed risk of 56 partici-
pants per 1000 having postoperative treatment failure after metal-
lic screw fixation, there is very low-quality evidence that 25 more
(95% CI 4 fewer and 69 more) participants had treatment failure
after bioabsorbable screw fixation. The main differences in indi-
vidual complications related to graft rupture and chronic knee ef-
fusion, both of which occurred more in the bioabsorbable screw
group; however, the 95% confidence interval crosses the line of no
effect for both analyses and thus includes the possibility of a higher
rate of these two complications in the metallic group. There was
very low-quality evidence of very similar activity levels in the two
groups at 12 and 24 months follow-up measured via the Tegner
score.
Overall completeness and applicability of
evidence
Although we included 12 trials that recruited 944 participants, the
data available for self-reported knee function and level of activ-
ity are far fewer, declining even more at longer follow-ups. Thus,
the pooled data for Lysholm scores amounted to 168 participants
(18% of 944) at 12 months, 113 (12%) at 24 months and 71
(7.5%) at five or more years. ’Treatment failure’ data were avail-
able for 11 trials (882 participants: 93% of total), but this out-
come was only specifically reported in one trial; the data in the
rest being derived from accounts of complications. Complications
were poorly reported and frequently justified as a reason for ex-
cluding participants, such as those with implant breakage or re-
injury (graft failure), from the analyses.
The study populations and interventions, including the grafts used
for ACL reconstruction, are all relevant to current practice. Al-
though not optimal, the outcomes collected are representative of
the outcomes (Lysholm and Tegner) that are often collected in
practice. Likewise, while treatment failure was inadequately re-
ported, being specifically reported in Hofmann 2001 only, the in-
dividual complications (implant breakage, graft rupture, effusion
and so on) listed are representative of those recorded in practice.
As noted by Fink 2000 and others, the bioabsorbable interference
screw is more expensive that a metallic screw. This is an important
consideration, but one that would be outweighed should other
advantages be proven. The evidence thus far does not support the
routine use of these screws, particularly in the light of greater treat-
ment failure after bioabsorbable screw fixation. However, there
will still circumstances, such as patients requiring postoperative
magnetic resonance imaging (MRI) where bioabsorbable screws
may be an attractive option.
Quality of the evidence
All trials were at high risk of bias, which invariably included per-
formance bias (see Figure 2 and Figure 3). Seven trials were at high
risk of attrition bias and eight at high risk of reporting bias. One
trial, which was quasi-randomised, was at high risk for selection
bias.
In our assessment of the quality of the evidence using GRADE,
we downgraded the evidence for all primary outcomes, two levels
because of the high risk of bias and one level for imprecision due to
insufficiency of the available data. We did not downgrade for indi-
rectness (see Overall completeness and applicability of evidence),
inconsistency (there was no evidence of statistical heterogeneity)
or publication bias (there were insufficient evidence to explore this
but the funnel plot for treatment failure did not reveal a skewed
distribution: see Figure 6).
Potential biases in the review process
Where possible, we performed this review in accordance with the
previously published protocol; all important deviations are noted
in Differences between protocol and review. While our database
search was comprehensive, we did not search conference proceed-
ings and this increases the possibility that, probably, small trials,
especially those unpublished or published only in conference pro-
ceedings, may have been missed. We were careful to avoid treating
different reports of the same trial as separate trials and thus avoided
serious problems relating to double counting of trial participants
that has occurred in other systematic reviews.
Agreements and disagreements with other
studies or reviews
We identified three published meta-analyses making the same
comparison (Emond 2011; Laupattarakasem 2014; Shen 2010).
Emond 2011, which searched the literature between 1999 to Au-
gust 2009, included eight studies, all of which appear in this re-
view. Emond 2011 concluded that there was no difference between
the metallic and bioabsorbable screws for any analysed outcome
based on a strict requirement for statistical significance set at P <
0.05. Similar to our review, Emond 2011 noted that the treatment
failures and intraoperative complications in the studies have not
been well-documented. However, our review found a more pro-
nounced result for treatment failure in favour of metallic screws.
Laupattarakasem 2014, which searched the literature between
1966 and June 2012, focused on complications and radiographic
outcomes and complications, claimed to include 11 studies but
actually referred to 11 articles, reporting results for eight trials.
In their analyses, they inappropriately pooled results from two
reports of McGuire 1995. Laupattarakasem 2014 found less im-
plant breakage, lower effusion rates and better healing of the tun-
nel when metallic screw was used. The authors concluded that the
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routine use of bioabsorbable fixation must be balanced according
to their advantages, disadvantages and cost.
Shen 2010, which searched the literature between 1966 and De-
cember 2008, reported 10 studies, but like Laupattarakasem 2014
failed to recognise that two ’studies’ were actually other reports of
two studies. In their analyses, they inappropriately pooled results
from two reports of Järvelä 2008. Shen 2010 concluded that joint
effusion was more common in the bioabsorbable screw group, but
otherwise did not find differences in other outcomes between the
two types of screws.
Mascarenhas 2015 conducted a review of meta-analyses on this
topic and included only the three aforementioned meta-analyses.
Mascarenhas 2015 did not identify the duplicate trial publication
issue for Laupattarakasem 2014 and Shen 2010. It concluded that
the “best available” evidence showed “prolonged knee effusion,
increased femoral tunnel widening, and increased screw break-
age” with bioabsorbable interference screw use. Mascarenhas 2015
concluded that cost-effectiveness studies would be valuable but
in the context of more specific situations or patient populations
where the “advantages” of bioabsorbable interference screws could
be used.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is very low quality but consistent evidence of no clinically
important difference in self-reported knee function at one, two
and five years or more between bioabsorbable versus metallic in-
terference screws for graft fixation in anterior cruciate ligament
(ACL) reconstruction. A similar finding applies to levels of activity
at one and two years. There is, also, very low quality but consistent
evidence of greater treatment failure with bioabsorbable interfer-
ence screws.
Implications for research
Given the lack of evidence to support bioabsorbable interference
screws, including the potential for a greater risk of treatment fail-
ure, further randomised trials testing routine use of bioabsorbable
screws compared with metallic interference screws do not appear
to be a priority. If such trials are undertaken, these should conform
to best design, conduct, analysis and reporting standards for ran-
domised controlled trials and avoid major conflicts of interest. As
well as careful selection of validated self-reported outcome mea-
sures, including those of knee function, such as the ACL Quality
of Life outcomemeasure (Mohtadi 1998), and activity levels, care-
ful monitoring and reporting of complications including overall
treatment failure is required. Minimum follow-up should be two
years with long-term follow-up of at least five years considered.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Arama 2015
Methods Study design: Randomised controlled trial.
Randomisation method: The type of fixation (bioabsorbable or metal screw) was de-
termined at the start of each procedure by opening a sealed envelope.
Assessor blinding: Two independent assessors, unaware of the screw type, performed
all preoperative and postoperative clinical assessment.
Follow-up: 5 years.
Loss to follow-up: 3 participants were lost to follow-up (7.5%).
Participants Places of study:North Sydney Orthopaedic and Sports Medicine Centre, Sydney, Aus-
tralia
Duration of the study: Between June 2002 and October 2003.
Number of participants: 40 participants assigned and 37 participants assessed.
Inclusion criteria: Primary ACL reconstruction with 4-stranded hamstring graft and
written informed consent to study
Exclusion criteria: Concurrent significant other ligament injury, chondral injury, more
than one-third meniscectomy, abnormal contralateral knee joint, patients seeking injury
compensation
Gender: 11 female, 29 male.
Mean age (years): 33 years old (bioabsorbable group); 29 years old (metallic group)
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1. Bioabsorbable group: Used hamstrings graft, fixed with PLLA with hydroxyapatite
(PLLA-HA) screw used both in femur and tibia.
2. Metallic group:Used hamstrings graft, fixed with titanium screw used both in femur
and tibia.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: 20 bioabsorbable versus 20 metallic.
Analysed (5 years ): 18 bioabsorbable versus 19 metallic.
Outcomes Length of follow-up: Five years.
Primary outcomes:
• Lysholm
• IKDC subjective questionnaire
• Failure of treatment and adverse events: effusion, graft rupture, implant breakage,
superficial and deep infections
Secondary outcomes:
• IKDC clinical examination
• Functional tests: single-leg hop test
• Knee stability: KT-1000; Lachman test; pivot-shift
• Range of knee movement
Publications and source of data used in re-
view
Arama 2015 was reported in three conference abstracts, one in 2007 (Pinczewski 2007)
reporting 2-year follow-up and two in 2012 (Pinczewski 2012a; Pinczewski 2012b), both
reporting five years follow-up. Finally, the main article was published in 2015 (Arama
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Arama 2015 (Continued)
2015), also with 5 years of follow-up.
Pinczewski 2007 reported 50 participants in the trial. We have accepted the number as
40 but as reported in the rest of the reports
Notes The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted (one post randomisation
exclusion)
“One or more of the authors has declared the following potential conflict of interest or
source of funding: Institutional research funds were received by L.A.P. from Smith &
Nephew Inc.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomised at the time of
consent via computer method.”
“In blocks of 20, these envelopes contained
cardswith thewordRCIorBioRCI in equal
numbers, in random order.”
Allocation concealment (selection bias) Low risk “Each envelope was numbered consecu-
tively on the outside. The envelopes were
sealed, and there was no information on
the outside of the envelope as to which card
was inside. On the day before the surgery,
an envelope was chosen from the box in
consecutive order by the surgeon’s secretary,
who had no involvement in the study, and
was inserted into the patients’ file, which
accompanied them to surgery. The enve-
lope was opened once the patient had en-
tered the operating room. The surgeon was
then instructed as to method of fixation.”
Thus allocation concealment was very
probably secure.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk While “the patients remained blinded
throughout the study”, the operating sur-
geon was not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Two independent physical therapists with
extensive experience in knee assessment,
unaware of the screw type, performed all
preoperative and postoperative clinical as-
sessment. The patients remained blinded
throughout the study.”
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Incomplete outcome data (attrition bias)
All outcomes
High risk An abstract published in 2007 reporting 2-
year follow-up stated there were 50 partic-
ipants. While small (3 out of 40) there was
also some slightly inconsistent reporting of
loss for follow-up at 5 years
Selective reporting (reporting bias) Unclear risk The study protocol is not available. While
the published reports included all expected
outcomes, the clinical data for two-year fol-
low-up were not provided
Other bias High risk “One or more of the authors has declared
the following potential conflict of interest
or source of funding: Institutional research
funds were received by L.A.P. from Smith
& Nephew Inc.”
Benedetto 2000
Methods Study design: Randomised controlled trial.
Randomisation method: Sealed envelopes.
Assessor blinding: Not reported.
Follow-up: Postoperative assessments were conducted at 3, 6, and 12 months following
surgery
Loss to follow-up: 10 participants were lost to follow-up (8%).
Participants Places of study: University Hospital of Innsbruck and University Hospital of Graz,
Austria; St. JosephZiekenhuis, Veldhoven;Carolus-LiduinaZiekenhuis,Herrogenbosch;
and Medisch Centrum, Alkmaar, The Netherlands
Duration of the study: Between August 1994 and March 1996.
Number of participants: 124 participants assigned and 114 participants assessed.
Inclusion criteria: Aged between 15 and 50 years requiring ACL replacement surgery
in a single knee; stable knee in extension and no severe osteoarthritic changes
Exclusion criteria: Exclusions were participants with a history of cruciate ligament
injury in the unaffected knee or previous ACL surgery to either knee
Gender: 89 female, 35 male.
Mean age (years): 27.
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1. Bioabsorbable group: Used patellar tendon graft, fixed with copolymer of polygly-
colic acid (PGA) and the elastomer trimethylene carbonate (PGA-TMC) screw. In 30
cases, bioscrew was used for both femur and tibia. In 24 cases, bioscrew was used on the
femur and metallic screw on the tibia. In 13 cases, additional fixation with staples was
used.
2. Metallic group: Used patellar tendon graft, fixed with titanium screw. In 41 cases
the metallic screw was used both on the tibia and femur. In 16 cases, additional fixation
with staples was used.
The same postoperative protocol for rehabilitation was used for both groups
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Assigned: 67 bioabsorbable versus 57 metallic.
Analysed (minimum 12 months): 62 bioabsorbable versus 52 metallic.
Outcomes Length of follow-up:Mean 13 months (range 10 to 22 months).
Primary outcomes:
• Subjective assessment of knee function (part of IKDC)
• Failure of treatment and adverse events: effusion, re-injury, implant breakage,
superficial and deep infections, symptomatic foreign body reactions to bioabsorbable
screws
Secondary outcomes:
• IKDC knee examination
• Knee stability: KT-1000; Lachman test; pivot-shift
• Range of knee movement
• Pain: assessed as either with or without pain
Publications and source of data used in re-
view
There was just one report of this trial.
Notes Supported by a grant from Smith & Nephew Inc. Endoscopy Division, Andovec Mas-
sachusetts
The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Low risk “Randomization to screw type was per-
formed by opening a sealed envelope at the
time of surgery.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk 10 participants were withdrawn without
explanation. Reasons for missing outcome
data were not described. Small discrepancy:
113 participants not 114 described as fol-
lowed up in text of report
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Selective reporting (reporting bias) High risk Authors failed to include outcomes consid-
ered as primary in this review. The study
protocol is not available
Other bias High risk The study was supported by a grant from
Smith & Nephew Inc. Endoscopy Divi-
sion, Andover Massachusetts. Moreover,
while the fixation on the femur was ran-
dom there are several types of fixation on
the tibia that were not randomised
Drogset 2005
Methods Study design: Randomised controlled trial.
Randomisation method: Although not reported in Drogset 2005, the later trial report
(Drogset 2011) describes use of envelopes.
Assessor blinding: Not reported; states only that ”The follow-ups were carried out by
the first author”.
Follow-up: Participants were assessed at 6, 12, and 24 weeks and at 1 year and 2 years
postoperatively (Drogset 2005). Themean follow-up timewas 7.5 years inDrogset 2011.
Loss to follow-up: 4 participants were lost to follow-up (9.7%).
Participants Place of study:Department ofOrthopaedics, UniversityHospital inTrondheim, Trond-
heim, Norway
Duration of the study: June 6, 2000 to November 21, 2001.
Number of participants: 41 participants assigned and 37 participants assessed.
Inclusion criteria: Patients with isolated ACL ruptures or ACL ruptures with additional
minor meniscal lesions and minor cartilage lesions (Outerbridge grades I and II).
Gender: 22 female, 19 male.
Mean age (years): 26.6.
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1.Bioabsorbable group:Usedpatellar tendongraft, fixedwith poly-L-lactic acid (PLLA)
screw randomised on femur. Type of screw used in the tibia is not mentioned.
2. Metallic group:Used patellar tendon graft, fixed with titanium screw randomised on
femur. Type of screw used in the tibia is not mentioned.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: 21 bioabsorbable versus 20 metallic.
Analysed: 18 bioabsorbable versus 19 metallic.
Outcomes Length of follow-up: 2 years in Drogset 2005; mean 7.5 years in Drogset 2011.
Primary outcomes:
• Function or disability measured by: Lysholm function score
• Patient-rated knee function: excellent, good, fair or poor
• Activity level: Tegner
• Failure of treatment and adverse events: clinical assessment of swelling, superficial
and deep infections, effusion, re-rupture
Secondary outcomes:
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• Knee stability: KT-1000; Lachman test; pivot-shift
• Knee range of motion
Publications and source of data used in re-
view
Drogset 2005 was first published with 41 randomised patients and with two-year follow-
up. The same patients were followed until seven years of follow-up were available and
published again (Drogset 2011). At seven-year follow-up (Drogset 2011), two patients
in the bioabsorbable group were excluded due to re-rupture. In this study, the number
of patients excluded (3 versus 1) was not balanced. Another study report that reported
on inflammatory mediators (C5a, TCC, and IL-8) rather than clinical outcomes is also
available (Drogset 2006).
Notes The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Unclear risk Drogset 2011 stated that randomisation
was accomplished according to the enve-
lope method. No mention of safeguards
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Surgery was carried out at our hospital by
four experienced ACL surgeons. Personnel
were likely not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk States that “the follow-ups were carried out
by the first author.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Missing outcome data balanced in num-
bers across intervention groups, with simi-
lar reasons for missing data across groups.
One participant in the metallic group was
excluded for re-rupture instead of being
included in “treatment failures” (Drogset
2005).
At 7-year follow-up (Drogset 2011), two
participants in the bioabsorbable group
were excluded for re-rupture. Also, the
numbers lost to follow-up were not bal-
anced
Selective reporting (reporting bias) Low risk The study protocol is not available but it is
clear that the published reports include all
expected outcomes
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Other bias Low risk The study appears to be free of other
sources of bias.
Fink 2000
Methods Study Design: Randomised controlled trial.
Randomisation method: “The mode of femoral fixation (bioabsorbable or metal screw)
was determined at the start of each procedure by opening a sealed envelope”.
Assessor blinding: Not reported.
Follow-up: Participants were evaluated at 3, 6, 12, and 24 months postoperatively
Loss to follow-up: 4 participants were lost to follow-up (10%).
Participants Place of study:University Hospital for Traumatology and the Department of Radiology
I, University Hospital Innsbruck, Innsbruck, Austria
Duration of the study: Not reported.
Number of participants: 40 participants assigned and 36 participants assessed.
Inclusion criteria: Closed growth plates, unilateral anterior laxity confirmed clinically
and with MRI, no previous knee ligament surgery, and the willingness to follow the
study protocol.
Gender: 11 female 11, 29 male.
Mean age (years): 28.2
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1. Bioabsorbable group: Used patellar tendon graft, fixed with copolymer of polyg-
lycolic acid (PGA) and the elastomer trimethylene carbonate (PGA-TMC) screw, ran-
domised in the femur. A metallic screw was used in the tibia in all cases.
2. Metallic group:Used patellar tendon graft, fixed with titanium screw randomised in
the femur. A metallic screw was used in the tibia in all cases.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: 20 each group.
Analysed: 18 each group.
Outcomes Length of follow-up: Follow-up was 24 months postoperatively.
Primary outcomes:
• Function or disability measured by: Lysholm function score
• Failure of treatment and adverse events: assessed by deep infection
• Activity Level: Tegner activity score
Secondary outcomes:
• IKDC knee examination
• Knee stability: KT-1000
Publications and source of data used in re-
view
Fink 2000 was published both in German (Hackl 2000) and English (Fink 2000).
Both studies included the same group of patients who underwent the same process of
randomisation and were evaluated according to the same outcomes
Notes The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Low risk States that “the mode of femoral fixation
(bioabsorbable or metal screw) was deter-
mined at the start of each procedure by
opening a sealed envelope”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data were balanced in
numbers across groups.
Selective reporting (reporting bias) Low risk The study protocol is not available but it is
clear that the published reports include all
expected outcomes
Other bias Low risk The study appears to be free of other
sources of bias.
Hegde 2014
Methods Study design: Randomised controlled trial.
Randomisation method: Not described.
Assessor blinding: Not described whether assessors were blinded.
Follow-up: Participants were evaluated at 3 months, 6 months and 1 year
Loss to follow-up:No participants were lost to follow-up.
Participants Place of study: Department of Orthopaedics, Yenepoya Medical College, Mangalore,
India
Duration of the study: August 2011 to July 2013.
Number of participants: 24 participants, all assessed.
Inclusion criteria: patients who were diagnosed to have complete ACL injuries (Grade
3); age group of 20 to 60 years
Exclusion criteria: patients with chronic ACL insufficiency with osteoarthritis, patients
with collaterals and /or PCL injuries
Gender: all were male.
Mean age (years): 27.8 years.
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Interventions Bioabsorbable versus metallic interference screws for distal (tibial) graft fixation in ACL
reconstruction. Used quadrupled hamstring grafts, single-bundle. In all cases, endobut-
ton was used as fixation in the femur
1. Bioabsorbable group: Quadrupled hamstring grafts fixed with bioabsorbable screw
(type not reported) in the tibia.
2. Metallic group: quadrupled hamstring grafts, fixed with metallic screw in the tibia
The postoperative protocol for rehabilitation was not reported
Assigned: 12 each group.
Analysed: 12 each group.
Outcomes Length of follow-up: 1 year postoperatively.
Primary outcomes:
• Function: assessed by Lysholm
• Activity level: assessed by Tegner activity level scale
Publications and source of data used in re-
view
There was just one report of this trial.
Notes The authors did not calculate the sample size.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were randomly put in two groups.
” The sequence generation was not de-
scribed
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants were lost to follow-up.
Selective reporting (reporting bias) High risk Authors failed to include outcomes consid-
ered as primary in this review. The study
protocol is not available
Other bias Low risk The study appears to be free of other
sources of bias.
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Methods Study Design: Randomised controlled trial.
Randomisation method: Not described.
Assessor blinding: Not described.
Follow-up:The patients were evaluated at 3, 6, 12 and 24months postoperatively ranged
from 24-32 months (average: 28 months)
Loss to follow-up:No participants were lost to follow-up.
Participants Place of study: BGU Trauma Center, Murnau, Germany.
Duration of the study: Between April 1996 and December 1996.
Number of participants: 30 participants assigned and 30 participants assessed.
Inclusion criteria:Only participants with an isolated rupture of the ACL were recruited
in this study
Exclusion criteria: Meniscal tears, osteochondral lesions and other injuries, metabolic
disease, alcoholism, mental disorders, previous operations on the same knee, chronic
ACL injuries (more than 8 weeks).
Gender: 6 female, 24 male.
Mean age (years): 31.6 (range 18 to 50)
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1.Bioabsorbable group:Usedpatellar tendongraft, fixedwith poly-L-lactic acid (PLLA)
screw both on the tibia and femur.
2. Metallic group: Used patellar tendon graft, fixed with titanium screw both on the
tibia and femur.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: 15 each group.
Analysed: 15 each group.
Outcomes Length of follow-up:Mean 28 months (range 24 to 32 months).
Primary outcomes:
• Failure of treatment and adverse events: infection, joint effusion, implant failure
(breakage)
• Activity level: as before, decreased, increased
Secondary outcomes:
• Knee function: The evaluation protocol represented a condensed form of the
information contained in the knee follow-up sheets proposed by the IKDC and by
Marshall et al. Categorical scale: normal, nearly normal, impaired, disturbed
• Knee stability: assessed by Lachman test
• Range of motion
• Pain: none, mild, significant
Publications and source of data used in re-
view
Hofmann 2001 was also originally published as abstract in 1999 in German (Wagner
1999). It was subsequently published twice: once in German (Sudkamp 2000) and then
in English (Hofmann 2001).
Notes The authors did not calculate the sample size.
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk States that “30 patients were divided into
both groups by a random order generated
prior to the study.”
Allocation concealment (selection bias) Unclear risk No description of allocation concealment.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were not
blinded. States that “Patients were in-
formed about the study and the randomi-
sation procedure.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants were lost to follow-up.
Selective reporting (reporting bias) Unclear risk Noprotocol. The study fails to present out-
comes considered important in this review.
Presents a non-validated score for quality
of life evaluation and fails in proper presen-
tation of treatment failures
Other bias Low risk The study appears to be free of other
sources of bias.
Järvelä 2008
Methods Study design: Randomised controlled trial.
Randomisation method: Closed envelopes.
Assessor blinding: Clinical assessments at the final follow-up were performed by an
independent and blinded examiner
Follow-up: The patients were evaluated at 1, 3, 6, 12 and 24 months postoperatively
Loss to follow-up: Varies, maximum 14 patients were lost to follow-up (22%).
Participants Places of study: Orthopaedic Department and Arthroscopic Center, Hatanpää Hos-
pital, Sports Clinic and Hospital Mehiläinen, Division of Orthopaedics and Trauma-
tology, Department of Trauma, Musculoskeletal Surgery and Rehabilitation, Tampere
University Hospital, Tampere University and Injury and Osteoporosis Research Center,
UKK Institute, Tampere, Finland
Järvelä 2008a publication
Duration of the study: March 2003 to May 2005.
Number of participants: 52 participants assigned and 50 assessed.
Moisala 2008 publication
Duration of the study: February 2003 to August 2005.
Number of participants: 62 participants assigned and 55 assessed.
Inclusion criteria: primary ACL reconstruction, closed growth plates, absence of liga-
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ment injury to the contralateral knee
Exclusion criteria: not reported.
Gender: 21 female, 41 male.
Mean age (years): 32 years.
Interventions Bioabsorbable versusmetallic interference screws for graft fixation in ACL reconstruction
1. Bioabsorbable group: Used hamstring graft, fixed with bioabsorbable screw (L-
lactide, D-lactide, and trimethylene carbonate) both on the tibia and femur.
2. Metallic group: Used hamstring graft, fixed with titanium screw both on the tibia
and femur.
The same postoperative protocol for rehabilitation was used for both groups
Järvelä 2008a publication
Assigned: 27 bioabsorbable versus 25 metallic.
Analysed: at 1-year follow-up: 23 for each group; at 2-year follow-up: 21 bioabsorbable
versus 20 metallic.
Moisala 2008 publication
Assigned: 31 bioabsorbable versus 31 metallic.
Analysed: at 2-year follow-up: 29 bioabsorbable versus 26 metallic.
Outcomes Length of follow-up: 24 months.
Primary outcomes:
• Knee function: assessed by Lysholm score
• Subjective knee function (part of IKDC: limitations in daily activities (which
might include sports), the score was 10 if there were no limitations, while the score was
0 if the patient was unable to perform his daily activities
• Failure of treatment and adverse events: assessed by re-injury and re-operation
Secondary outcomes:
• IKDC knee examination
• Knee stability: assessed by KT-1000, pivot-shift test
Publications and source of data used in re-
view
There are several publications for this trial, which usually present interim data. Järvelä
2008was published twice as an abstract (Järvelä 2005; Jarvinen 2007). The first full report
was from 2005 (Järvelä 2005) and it was published again in 2007 (Jarvinen 2007) with
incomplete data. One main report was published in 2008 (Järvelä 2008a); this reported
on 77 participants in three groups (one group of 25 participants undergoing double-
bundle reconstruction does not feature in this review). Results for the bioabsorbable
versus metallic screw comparison for an extended recruitment period (62 participants)
were reported in the same year (Moisala 2008). Another report of this series was published
in 2012 (Suomalainen 2012), with five years of follow-up on the double-bundle versus
single-bundle reconstruction comparison
Notes The authors did not calculate the sample size.
It was unclear if an intention-to-treat analysis was conducted
This study includes a third group (25 participants in Järvelä 2008a) in which ACL recon-
struction was performed with a double-bundle technique and fixation was accomplished
with bioabsorbable interference screw. Data from this group were not included in this
review
Communication fromHelenHandoll (24March 2015) informed us that all these reports
pertained to the same trial. This was confirmed in the Cochrane review comparing
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double versus single-bundle fixation (Tiamklung 2012).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Unclear risk States that “These patients were ran-
domised with closed envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk States that “All clinical assessments at the
final follow-up were performed by an inde-
pendent and blinded examiner”
Incomplete outcome data (attrition bias)
All outcomes
High risk Varies in different publications and only
partly accounted for. Some post-randomi-
sation exclusion because of complications.
Imbalances between groups
Selective reporting (reporting bias) High risk The reporting in several publications of dif-
ferent outcomes for different sized popula-
tions at different follow-up times puts this
trial at high risk of selective reporting bias.
Also, treatment failures should have been
more specifically described
Other bias Unclear risk The study appears to be free of other
sources of bias.
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Kaeding 2005
Methods Study design: Quasi-randomised controlled trial.
Randomisation method: allocation based on last digit of participant’s hospital identi-
fication number.
Assessor blinding: Not described.
Follow-up: Participants were evaluated at 12 and 24 months postoperatively. Evaluation
of activity level as well as subjective evaluation of IKDC were reported at 1 year and at
2 years
Loss to follow-up: not reported for 1-year follow-up; 32 participants lost to 2-year
follow-up (33%)
Participants Place of study: Department of Orthopaedics, The Ohio State University, Columbus,
Ohio; and OrthoIndy, Indianapolis, Indiana, USA
Duration of the study: Not reported.
Number of participants: 97 participants assessed at 1-year follow-up and 65 at 2 years.
Number of patients assigned was not reported
Inclusion criteria: Not reported.
Exclusion criteria: Previous ACL or posterior cruciate ligament (PCL) reconstruction,
multiple ligament injured knees, active infection, morbid obesity, PCL insufficiency,
skeletal immaturity, history of rheumatoid arthritis or gout, prior articular or patellar
fractures, multiligament-injured knees and severe degenerative joint disease.
Gender: 32 female, 65 male.
Mean age (years): 26.9.
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1.Bioabsorbable group:Usedpatellar tendongraft, fixedwith poly-L-lactic acid (PLLA)
screw both on the tibia and femur.
2. Metallic group: Used patellar tendon graft, fixed with titanium screw both on the
tibia and femur.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: not reported.
Analysed: 48 bioabsorbable versus 49 metallic (1 year).
Outcomes Length of follow-up: The follow-up ranged from 12 and 24 months. Evaluation of
activity level as well as subjective evaluation of IKDC were reported at 1 year and at 2
years. KT- 1000 arthrometer, range of motion, presence of effusions, and complications
intraoperatively or postoperatively were also reported at 1 and 2 years
Primary outcomes:
• Function: assessed by subjective evaluation using the IKDC (no results reported)
• Failure of treatment and adverse events: implant breakage, superficial and deep
infection, effusion (none, mild), swelling with activity (strenuous, moderate, sedentary)
• Activity level: Assessed by a subjective scale (strenuous, moderate, light, sedentary)
Secondary outcomes:
• Knee stability: KT-arthrometer
• Knee range of motion
• Pain
Publications and source of data used in re-
view
There was just one report of this trial.
46Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kaeding 2005 (Continued)
Notes The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk The study was quasi-randomised. States
that “All patients were randomised into 1
of 2 groups according to the last digit of
their hospital identification number”
Allocation concealment (selection bias) High risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
Incomplete outcome data (attrition bias)
All outcomes
High risk The study did not mention the number of
patients that were allocated, so it is not pos-
sible to calculate the losses during the first
12-month follow-up
Authors states that there were 33% of lost
to follow-up in 24 months. Despite being
balanced across groups, these losses were
unexplained
Selective reporting (reporting bias) High risk The study protocol is not available. IKDC
score was pre-specified and not described
in the results section
Also, the study fails to provide outcomes
considered important in this review, such
as Lysholm score, IKDC, Tegner or SF-36.
Invalidated questionnaires were used to as-
sess pain, activity level, giving way and ef-
fusion
Other bias Low risk The study appears to be free of other
sources of bias.
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Kotani 2001
Methods Study design: Randomised controlled trial.
Randomisation method: Not described.
Assessor blinding: Not described whether assessors were blinded.
Follow-up: The average postoperative follow-up period was 20 months in the bioab-
sorbable group and 22 months in the metallic group
Loss to follow-up:Noparticipants were lost to follow-up but it is not clear if all recruited
participants were recorded
Participants Place of study: Department of Orthopaedic Surgery, Kyorin University School of
Medicine, Shinkawa, Mitaka-shi, Tokyo, Japan
Duration of Study: not reported.
Number of participants: 91 participants assessed (number of patients assigned not
reported)
Inclusion criteria: not reported.
Exclusion criteria: not reported.
Gender: 36 female, 55 male.
Mean age (years): 23.9
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1.Bioabsorbable group:Usedpatellar tendongraft, fixedwith poly-L-lactic acid (PLLA)
screw. It is not clear if the screw was used in the tibia, femur, or both.
2. Metallic group: Used patellar tendon graft, fixed with titanium screw. It is not clear
if the screw was used in the tibia, femur, or both.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: not reported.
Analysed: 46 bioabsorbable versus 45 metallic.
Outcomes Length of follow-up:mean 21 months.
Primary outcomes
• Function and quality of life: Japanese Orthopaedic Association (JOA) score.
• Failure of treatment and adverse events: synovitis and implant breakage.
Secondary outcomes
• Knee stability: KT-1000; Lachman test, pivot-shift test
• Range of knee movement: arthrofibrosis
Publications and source of data used in re-
view
There was just one report of this trial.
Notes The authors did not calculate the sample size.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Unclear risk Not described.
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Participant flow unclear. It was not clear
whether any participants were lost to fol-
low-up
Selective reporting (reporting bias) High risk The study protocol is not available and the
authors did not pre-specify the outcomes
at each time point
Other bias High risk The study had a potential source of bias:
time of evaluations and follow-up were not
described; inclusion and exclusion criteria
were not described
Laxdal 2006
Methods Study design: Randomised controlled trial.
Randomisation method: Randomisation was accomplished by using sealed envelopes.
Assessor blinding: Two independent physical therapists who were not involved in the
rehabilitation performed all the preoperative and postoperative assessments (Laxdal
2006). “The long-term follow-up was performed by only 1 of the physiotherapists”
(Stener 2010).
Follow-up: Participants were evaluated on the first postoperative day, at 6 months, and
at 2 years (Laxdal 2006). Bioscrew Group, mean 99 months and metallic screw Group,
mean 96 months (Stener 2010).
Loss to follow-up: Nine participants were lost to follow-up (11.6%) in the first two
years of follow-up (Laxdal 2006). Thirteen were lost to follow-up at 96 months (17%)
(Stener 2010).
Participants Place of study: Department of Orthopaedics, Sahlgrenska University Hospital/Östra,
Göteborg, Sweden
Duration of Study: Between January 1999 and March 2000.
Number of participants: 77 participants assigned and 68 participants assessed (Laxdal
2006) and 64 were assessed at 96 months (Stener 2010).
Inclusion criteria: unilateral ACL rupture verified clinically by a positive Lachman test
result and positive pivot-shift test result or through a previous diagnostic arthroscopy
Exclusion criteria: associated PCL injury, collateral ligament laxity more than +1 com-
pared with the contralateral side, previous knee ligament surgery, contralateral knee lig-
ament injury, radiographically verified osteoarthritis.
Gender: 18 female, 50 male.
Mean age (years): 26.5.
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Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1. Bioabsorbable group: Used hamstring grafts, fixed with poly-L-lactic acid (PLLA)
screw both in the tibia and femur.
2. Metallic group: Used hamstring grafts, fixed with metallic screw both in the tibia
and femur.
All the procedures were performed by the senior author.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: 38 bioabsorbable versus 39 metallic.
Analysed: 36 bioabsorbable versus 32 metallic.
Outcomes Length of follow-up: Participants were evaluated on the first postoperative day, at 6
months, and at 2 years (Laxdal 2006) and 96 months (Stener 2010).
Primary outcomes:
• Function or disability measured by: Lysholm function score
• Activity Level: Tegner activity score
• Failure of Treatment ad adverse events: re-injury, infection.
Secondary outcomes:
• IKDC knee examination
• Objective function tests: single-leg hop test
• Knee stability: KT-1000
• Knee range of motion
Publications and source of data used in re-
view
Laxdal 2006was publishedwith the initial follow-up in2006.The authors chose to follow
these patients further and their results were reported again at the American Academy of
Orthopaedic Surgeons 76th Annual Meeting in 2009 (Stener 2009). The study with the
final follow-up was published in 2010 (Stener 2010).
Notes The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Unclear risk “Randomisation was performed using
closed envelopes”.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Two senior surgeons performed all the re-
constructions. Participants and personnel
were likely not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Laxdal 2006: “Two independent physical
therapists who were not involved in the re-
habilitation performed all the preoperative
and postoperative assessments”
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Laxdal 2006 (Continued)
Stener 2010: “The long-term follow-up
was performed by only 1 of the physiother-
apists”
Incomplete outcome data (attrition bias)
All outcomes
High risk Missing outcome data were not balanced in
numbers across intervention. Two partic-
ipants of bioabsorbable screw group were
excluded because of re-rupture. Seven were
excluded from the metallic screw group,
one for re-rupture. The other six were not
mentioned. Reasons for exclusions were
partially described
Selective reporting (reporting bias) High risk The study protocol is not available. Fail-
ures such as implant breakage and graft lost
were not mentioned or included as an out-
come. Also, infection and re-rupture were
described but not included as an outcome.
The need for re-operation should have been
described more clearly.
Other bias Unclear risk Both reports seemed to include the same
participants. However, it is unclear if the
study is free of other sources of bias
McGuire 1995
Methods Study design: Randomised controlled trial.
Randomisation method: States that “permutated block of four was used. A computer
program was used to generate the randomisation of patients into the two groups. The
participating clinicians were given sealed envelopes containing cards indicating into
which group the patient was enrolled” (McGuire 1999).
Assessor blinding: Not reported.
Follow-up: One and two years (McGuire 1995a). In McGuire 1999, the average follow-
up interval was 28 months (range 11 to 64 months). Average follow-up for Barber 2000
was 35 months.
Loss to follow-up: 40 participants were lost to follow-up at 1 year (20%), 87 at 2 years
(43%) (McGuire 1999).
Participants Places of study: Plano Orthopedic and Sports Medicine Center, Plano, Texas; Southern
Sports Medicine and Orthopaedic Center, Nashville, Tennessee; Knee and Arthroscopic
Surgery, Anchorage, Alaska and the Orthopedic Specialty Hospital, Salt Lake City, Utah
- USA
Duration of the study: April 1992 to May 1994.
Number of participants: 204 participants. There were 148 participants assessed at 1-
year follow-up and 39 at 2 years in McGuire 1995a; and 164 assessed at 1 year and 117
at 2 years in McGuire 1999. For the 117 participants having patellar tendon graft, 114
participants were assigned and 85 participants assessed in Barber 1995 and Barber 2000.
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McGuire 1995 (Continued)
Results for these 85 participants are used in the review.
Inclusion criteria:Unilateral knee instability, positive Lachman’s andpositive pivot-shift
tests, KT maximum manual side-to-side differences greater than 3 mm, a minimum age
of 16 years with nearly closed knee growth plates, adequate bone density, compliance with
the study protocol, and a commitment for at least two years follow-up knee; no previous
surgeries in the index knee, chondral lesion Outerbridge grade III, no patellofemoral
symptoms, absence of systemic illnesses
Exclusion criteria: Active infection, history of blood supply limitations and/or previous
infections that could retard healing, torn PCL, prior knee ligament replacement.
Gender: 66 female, 138 male (McGuire 1995a).
Mean age (years): 30.0
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
Used patellar tendon graft in 117 participants, patellar tendon allograft in 59, Achilles
allograft in 25, allograft together with autograft in 2, and semitendinous autograft in 1.
1. Bioabsorbable group: Fixed with poly-L-lactic acid (PLLA) screws both in the tibia
and femur in 83 patients, staples in the tibial side were used in 17 and screws with
washers in 3 participants.
2. Metallic group: Fixed with metal screws in both ends in 75 patients. In the tibial
side, staples were used in 23 and screws with washers in 2 participants.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: 103 bioabsorbable versus 101 metallic.
Analysed: 89 bioabsorbable versus 75metallic (minimum 12months); 61 bioabsorbable
versus 56 metallic (minimum 24 months)
From Barber 1995 (patellar tendon autograft only).
Assigned: 54 bioabsorbable versus 60 metallic.
Analysed: 51 bioabsorbable versus 59metallic (minimum 12months); 42 bioabsorbable
versus 43 metallic (mean 19 months, range 12 to 33 months). Barber 2000: 34 in both
groups (mean 35 months, range 24 to 65 months).
Outcomes Length of follow-up: Postoperative assessments were recorded at one and two years
(McGuire 1995a). In McGuire 1999, mean 28 months (range, 11 to 64 months). In
Barber 1995, minimum 1-year follow-up; mean 35 months (range 24 to 65 months) in
Barber 2000.
Primary outcomes:
• Function: Lysholm
• Failure of treatment and adverse events: assessed by lytic inflammatory response
and effusion, infection, implant breakage, graft loss
• Activity level: Tegner score
Secondary outcomes:
• Knee stability: KT; Lachman; pivot-shift
• Knee range of motion
Publications and source of data used in re-
view
Patients reported on initially in McGuire 1995a were subsequently described in several
additional publications. The study was a multicentre, randomised study that included
several non-randomised types of graft (patellar tendon, hamstrings, and allograft) and
additional fixation devices. The authors state that 204 participants were enrolled in
the trial (McGuire 1995a). Of those, 117 underwent ACL reconstruction with patellar
tendon. At a minimum of 12-month follow-up (12 to 33 months, average 19 months)
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McGuire 1995 (Continued)
, Barber 1995 reported on 85 of these participants. Results for the 204 participants
were published at a mean 30 months follow-up in McGuire 1999. At a minimum of
24-month follow-up, 68 participants with patellar tendon autograft were available for
further follow-up (Barber 2000). Results for participants treatedwith different graft types
and different fixation devices rather than patellar tendon autografts were not included
in this review
Notes The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
Medial collateral ligament (MCL) or lateral collateral ligament (LCL) injuries requiring
repair in addition to the index procedure occurred in 15 cases, and one of these cases had
an extra-articular augmentation with an iliotibial band tenodesis; ACL reconstruction
with no other ligament involvement occurred in 189 cases (175 with a single graft, 14
with iliotibial band tenodesis) (McGuire 1999).
In 2 cases, the bioscrew broke in fragments smaller than 1.5 cm in length, being left in
situ, and supplemented with a metal screw in each case. These patients remained in the
Bioscrew group, tracked for complications and had none (McGuire 1999).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk McGuire 1999: “permutated block of four
was used. A computer program was used to
generate the randomisation of patients into
the two groups.”
Allocation concealment (selection bias) Low risk McGuire 1999: “The participating clini-
cians were given sealed envelopes contain-
ing cards indicating into which group the
patient was enrolled”
Barber 1995: “Once accepted into the
study, a randomised sealed envelope was
opened revealing the patient’s assignment
to either the Bioscrew group or the metal
screw group.”
Barber 2000: “Randomization was accom-
plished by using sealed envelope opened af-
ter acceptance into the study that revealed
the patient’s assignment to either the Bio-
screw group or the metal screw group.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described whether assessors were
blinded.
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McGuire 1995 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk McGuire 1999: There were 20% of pa-
tients lost at 1 year and 43% at 2 years of
follow-up
Barber 1995: Missing outcome data were
not balanced in numbers across interven-
tion groups. There was unexplained lost
during follow-up of 34% of patients
Barber 2000: The results for only 68 par-
ticipants (60%) for whom 2-year follow-up
data were available were reported
Selective reporting (reporting bias) High risk The study protocol is not available. Al-
though it is clear that the published reports
include all expected outcomes, the report-
ing of interim findings could point to se-
lective reporting bias
Other bias Unclear risk Both reports seemed to include the same
participants. However, it is unclear if the
study is free of other sources of bias
Myers 2008
Methods Study design: Randomised controlled trial.
Randomisation method: States that “patients were assigned by use of block randomi-
sation with consecutively numbered sealed envelopes”
Assessor blinding: The clinical assessors were blinded to the type of interference screw
used in each case.
Follow-up: The follow-up was two years. Participants were assessed preoperatively and
at 3, 6, 12, and 24 months postoperatively
Loss to follow-up: 14 patients were lost to follow-up (12.2%).
Participants Place of study: Brisbane Orthopaedic and Sports Medicine Centre, Brisbane Private
Hospital, Brisbane, Australia, and the Institute of Health and Biomedical Innovation,
Queensland University of Technology, Brisbane, Australia
Duration of Study: February 2002 to January 2005.
Number of participants: 114 participants assigned and 100 participants assessed. (Al-
location known from 3 additional excluded participants with complications.)
Inclusion criteria: Participants awaiting ACL reconstruction.
Exclusion criteria: Participants with skeletal immaturity, multi-ligament injury, con-
tralateral knee ligament injury, previous knee ligament surgery, advanced degenerative
and joint disease (Outerbridge grade IV).
Gender: 42 female, 58 male.
Mean age (years): 30.1.
Interventions Bioabsorbable versusmetallic interference screws for graft fixation inACL reconstruction.
1. Bioabsorbable group: Used hamstring grafts, fixed with PLLA with hydroxyapatite
(HA-PLLA) screw both on the tibia and femur.
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Myers 2008 (Continued)
2. Metallic group: Used hamstring grafts, fixed with titanium screw both on the tibia
and femur.
Surgery performed by one experienced surgeon and envelope was opened just prior to
fixation of the graft.
The same postoperative protocol for rehabilitation was used for both groups
Assigned: not clear.
Analysed (minimum12months):50bioabsorbable versus 50metallic. For complications
including exclusions: 52 bioabsorbable versus 51 metallic
Outcomes Length of follow-up: 2 years.
Primary outcomes:
• Function: Lysholm function score
• Failure of treatment and adverse events: Implant breakage and re-injury
Secondary outcomes:
• IKDC knee examination
• Knee stability: instrumented laxity tests, Rolimeter, pivot-shift test
Publications and source of data used in re-
view
There was just one report of this trial.
Notes One patient in the bioabsorbable group sustained breakage of the screw head during
insertion, the patient was excluded from the study. There were 2 ruptures of autograft,
1 in each group, occurring at 6 months in the HA-PLLA group (body surfing) and at
14 months in the titanium group (soccer). These 2 participants were excluded from the
final analysis
Study partially funded by Smith & Nephew. The authors report no conflict of interest
The authors did not calculate the sample size.
It was unclear if intention-to-treat analysis was conducted.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The sequence generation was not de-
scribed.
Allocation concealment (selection bias) Low risk States that ”patients were assigned by use
of block randomisation with consecutively
numbered sealed envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel were likely not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The clinical assessors were blinded to the
type of interference screw used in each case
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Incomplete outcome data (attrition bias)
All outcomes
High risk The allocation of 10 participants who were
lost to follow-up was not given. There were
4 post-randomisation exclusions for com-
plications: 2 participants with re-rupture, 1
with implant breakage and 1 with effusion
linked to lupus
Selective reporting (reporting bias) High risk Failure of treatmentwas not assessed as out-
come.
Other bias High risk The study was supported by a grant from
Smith & Nephew Inc.
ACL: anterior cruciate ligament
IKDC: International Knee Documentation Committee
MRI: magnetic resonance imaging
PCL: posterior cruciate ligament
PGA: polyglycolic acid
PLLA: poly-L-lactic acid
TMC: trimethylene carbonate
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Barber 1999 This study reports an histological study involving 19 sheep and results from McGuire 1995 for the subgroup
reported in Barber 2000. It provides no new evidence and we chose to exclude it due to the extensive description
and emphasis on basic science
Bourke 2013 This study is a randomised clinical trial comparing two types of bioabsorbable interference screws. Thus, it does
not address the desired comparison of this review
De Wall 2011 This is a randomised controlled trial where tibial fixation was randomised to metal interference screw and staples
or a centrally placed polyethylene screw and sheath implant. It was excluded because of the additional fixation,
which was different for each type of screw
Denti 2004 Not a randomised controlled trial.
Harilainen 2009 This study is a randomised clinical trial that analysed the difference between Rigidfix cross-pin and Intrafix
tibial expansion sheath with a tapered expansion screw; Rigidfix femoral and BioScrew interference screw tibial
fixation, BioScrew femoral and Intrafix tibial fixation; or BioScrew fixation into both tunnels. Thus, it does not
cover the comparison sought
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Jagodzinski 2010 In this randomised clinical trial, participants were allocated to have their graft fixed in the tibial tunnel with
either an interference screw or press-fit fixation with a bone cylinder. Thus, it does not accomplish the desired
comparison
Kocabey 2003 This is a cadaveric study.
P omi ski 2008 Not a randomised controlled trial.
Tecklenburg 2006 This study compares three types of non-metallic screws.
Characteristics of studies awaiting assessment [ordered by study ID]
Imbert 1999
Methods Method of randomisation: states random, but no description regarding methodology is provided.
Assessor blinding: not mentioned
Loss to follow-up: 9 cases at 12 months and 18 at 24 months.
Participants 50 participants with ACL injury requiring surgical reconstruction were included.
Inclusion criteria: ACL injury
Exclusion criteria: Age < 17 and > 40 years, bilateral ACL injury and repeat surgery.
Country: not mentioned
Period of study: not mentioned
Gender: not mentioned
Age: not mentioned
Interventions Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction
1. Bioresorbable intervention: states bioresorbable polylactic acid interference screw.
2. Non-resorbable intervention: states metallic titanium interference screw.
Postoperative management: not mentioned
Outcomes The following outcomes were presented:
• Lysholm (states no difference, provide no details)
• IKDC (states no difference, provide no details)
• Tegner (states no difference, provide no details)
• Radiological assessment included standard x-rays and MRI
Notes Available only in a conference abstract. We tried unsuccessfully to contact the authors to obtain further information
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Imhoff 1997
Methods Method of randomisation: states random, but no descriptions regarding methodology is provided.
Assessor blinding: not mentioned
Loss to follow-up: 17 in the bioresorbable group (35%) and 10 in the control group (21%) after one year
Participants 96 participants with ACL injury requiring surgical reconstruction were included.
Inclusion criteria: unilateral ACL insufficiency, laxity > 3 millimetres side-to-side difference using KT-2000
Exclusion criteria: associated PCL injury, or prior knee ligament surgery.
Country: Germany
Period of study: April 1993 to July 1995
Gender: not mentioned
Age: not mentioned
Interventions Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction
1. Bioresorbable intervention: states bioresorbable interference screw, provides no details
2. Non-resorbable intervention: states metallic interference screw, provides no details
Postoperative management: not mentioned
Outcomes The following outcomes were presented:
• Complications
• Functional outcome
Notes Available only in a conference abstract. We tried unsuccessfully to contact the authors to obtain further information
Toljan 1996
Methods Method of randomisation: states random allocation with sealed envelopes, but no description is given regarding the
method used.
Assessor blinding: not mentioned
Lost to follow-up: None
Participants 60 participants with ACL injury were included.
Inclusion criteria: not mentioned
Exclusion criteria: not mentioned
Country: Hungary
Period of study: not mentioned
Gender: not mentioned
Age: not mentioned
Assigned: 30 bioresorbable and 30 stainless steel.
Interventions Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction
1. Bioabsorbable group: states bioresorbable interference screw, provides no details
2. Metallic group: states metallic interference screw, provides no details.
Postoperative protocol for rehabilitation was not mentioned
Outcomes The following outcomes were presented:
• Functional outcome
• Complications
• MRI results
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Toljan 1996 (Continued)
Notes Available only in a conference abstracts. We tried unsuccessfully to contact the authors to obtain further information
ACL: anterior cruciate ligament
IKDC: International Knee Documentation Committee
MRI: magnetic resonance imaging
PCL: posterior cruciate ligament
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D A T A A N D A N A L Y S E S
Comparison 1. Bioabsorbable versus metallic interference screws
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Function (Lysholm knee score: 0
to 100; higher scores = better
function)
5 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 Lysholm 12 months 3 168 Mean Difference (IV, Fixed, 95% CI) -0.08 [-1.48, 1.32]
1.2 Lysholm 24 months 3 113 Mean Difference (IV, Fixed, 95% CI) 0.35 [-1.27, 1.98]
1.3 Long term (5 years or
more)
2 71 Mean Difference (IV, Fixed, 95% CI) 1.23 [-2.00, 4.47]
2 Subjective assessment of knee
function: normal or nearly
normal/excellent or good
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 At 12 months 2 149 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.91, 1.05]
2.2 At 24 months 2 67 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.85, 1.26]
2.3 At 7 years 1 34 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.76, 1.16]
3 Overall treatment failure 11 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Intraoperative and
postoperative complications
11 885 Risk Ratio (M-H, Fixed, 95% CI) 1.94 [1.29, 2.93]
3.2 Postoperative
complications
11 885 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [0.93, 2.23]
4 Individual adverse events
(complications)
11 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Implant failure or
breakage
7 689 Risk Ratio (M-H, Fixed, 95% CI) 6.88 [1.85, 25.56]
4.2 Infection 8 604 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.36, 2.36]
4.3 Graft rupture 8 631 Risk Ratio (M-H, Fixed, 95% CI) 1.70 [0.69, 4.19]
4.4 Symptomatic foreign body
reactions
3 369 Risk Ratio (M-H, Fixed, 95% CI) 2.52 [0.10, 60.67]
4.5 Joint effusion 6 489 Risk Ratio (M-H, Fixed, 95% CI) 1.54 [0.76, 3.11]
4.6 Arthrofibrosis, cyclops
lesion, adhesions
3 379 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.34, 1.82]
4.7 Graft damage (during
surgery)
1 124 Risk Ratio (M-H, Fixed, 95% CI) 2.55 [0.27, 23.87]
5 Activity level (Tegner scores: 0
to 10; higher scores = greater
activity)
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Tegner 12 months 2 122 Mean Difference (IV, Fixed, 95% CI) 0.08 [-0.39, 0.55]
5.2 Tegner 24 months 2 72 Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.54, 0.57]
6 Activity level 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 Decreased activity level at
1 year
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Decreased activity level at
2 years
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Light or sedentary activity
only at 2 years
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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7 IKDC knee examination results:
normal or nearly normal
5 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 At 12 months 2 160 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.94, 1.12]
7.2 At 24 months 3 145 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.93, 1.27]
7.3 Long term (5 years) 1 37 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.90, 1.11]
8 Objective function tests 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 Single-leg hop test success
at 24 months
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Single-leg hop test success
at long term (5 years)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Knee stability: KT-1000 (mm) 8 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 6 months 2 83 Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.53, 0.39]
9.2 12 months 6 473 Mean Difference (IV, Fixed, 95% CI) 0.06 [-0.12, 0.24]
9.3 24 months 4 178 Mean Difference (IV, Fixed, 95% CI) 0.05 [-0.39, 0.49]
9.4 Long term (5 or more
years)
2 68 Mean Difference (IV, Fixed, 95% CI) -0.48 [-1.39, 0.42]
10 Knee instability: objective tests 8 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10.1 KT-1000 or Rolimeter
3+ mm at 12 months
4 321 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.66, 1.44]
10.2 KT-1000 or Rolimeter
3+ mm at 24 months
3 173 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.56, 2.09]
10.3 KT-1000 3+ mm at 7
years
1 31 Risk Ratio (M-H, Fixed, 95% CI) 1.6 [0.56, 4.58]
10.4 Positive Lachman test at
12 months
2 118 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.53, 1.56]
10.5 Positive Lachman test at
24 months
4 224 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.64, 1.49]
10.6 Positive Lachman test
long term (5 or more years)
2 68 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.56, 1.73]
10.7 Positive pivot-shift test at
12 months
5 377 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.67, 1.73]
10.8 Positive pivot-shift test at
24 months
5 335 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.75, 1.80]
10.9 Positive pivot-shift test
long term (5 or more years)
2 68 Risk Ratio (M-H, Fixed, 95% CI) 0.39 [0.13, 1.11]
11 Range of knee movement
(degrees) at two years
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 ’Flexion limit’ 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.2 ’Extension limit’ 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Range of knee movement
deficits
6 421 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.83, 1.67]
13 Pain (persistent) 2 144 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.26, 3.41]
14 Overall treatment failure
(intraoperative and
postoperative): for funnel plot
11 882 Risk Ratio (M-H, Fixed, 95% CI) 1.95 [1.29, 2.93]
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A D D I T I O N A L T A B L E S
Table 1. Details of ACL reconstruction and interventions used in the included studies
Study ID Bioabsorbable
screw
Metal screw Randomised site
(s)
Other site Type of graft Other info
Arama 2015 PLLA with hy-
droxyapatite
(HA-PLLA)
Titanium Femur & tibia N/A Hamstrings
Benedetto 2000 Copoly-
mer of polygly-
colic acid (PGA)
and the elas-
tomer trimethy-
lene carbonate
(PGA-TMC)
Titanium Femur Used bioab-
sorbable screw in
both sites in 30
cases. Bio screw
in the femur and
metal screw in
tibia in 24 cases.
Bio screw in the
femur with sta-
ples in the tibia
in 13 cases. Metal
screw in both sites
in 41 cases. Metal
screw in the fe-
mur with staples
in the tibia in 16
cases
Patellar tendon Tibial fixa-
tion was achieved
with either the al-
located screw or a
standard fixation
device
Drogset 2005 Poly-L-lactic
acid (PLLA)
Not stated Femur The
bone block in the
tibial tunnel was
fixed with an in-
terference screw.
Type of screw not
stated
Patellar tendon
Fink 2000 Copoly-
mer of polygly-
colic acid (PGA)
and the elas-
tomer trimethy-
lene carbonate
(PGA-TMC)
Titanium Femur Titanium screw. Patellar tendon
Hegde 2014 Not stated Not stated Tibia Endobutton used
for femur.
Hamstrings “In all patients,
femoral fixations
were achieved
by using endobut-
tons and tibial fix-
ations were
achieved by using
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Table 1. Details of ACL reconstruction and interventions used in the included studies (Continued)
either metallic or
bioabsorbable in-
terference screws,
based on their
randomisation.”
Hofmann 2001 Poly-L-lactic
acid (PLLA)
Titanium Femur & tibia N/A Patellar tendon Screw was made
of Poly-L-lac-
tide (98% L-lac-
tide, 2% D-lac-
tide)
Järvelä 2008 PLLA/TMC/
PDLA
Titanium Femur & tibia N/A Hamstrings Poly-L-
lactide, D-lactide,
and trimethylene
carbonate, bioab-
sorbable screw
Kaeding 2005 Poly-L-lactic
acid (PLLA)
Titanium Femur & tibia N/A Patellar tendon
Kotani 2001 Poly-L-lactic
acid (PLLA)
Titanium Not stated Not stated Patellar tendon
Laxdal 2006 Poly-L-lactic
acid (PLLA)
Titanium Femur & tibia N/A Hamstrings
McGuire 1995 Poly-L-lactic
acid (PLLA)
Titanium Femur & tibia States: “In 158
cases, a PLLA (n
= 83) or metal
screw (n = 75)
was used to se-
cure the graft on
both ends. Staples
(B = 17, M = 23)
and screws with
washers (B = 3,
M = 2) were used
to secure grafts
at the tibial end
in 45 reconstruc-
tions when
Achilles ten-
dons were used or
when patella alta
conditions were
present. Those
patients who had
Patellar tendon
etc1
Separate data pro-
vided for patel-
lar tendon group
(Barber 1995 and
Barber 2000)
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Table 1. Details of ACL reconstruction and interventions used in the included studies (Continued)
staples or screws
with washers used
for tibial fixation
had a single inter-
ference screw in-
serted at
the femoral end of
their grafts. Aug-
mentation by ili-
otibial band ten-
odesis was per-
formed on 14
(B = 5, M = 9) pa-
tients.” (McGuire
1999)
Myers 2008 PLLA with hy-
droxyapatite
(HA-PLLA)
Titanium Femur & tibia N/A Hamstrings
1. The data used in this review are from two trial reports presenting the results for the subgroup of participants who had patella tendon
autografts. A report of the full trial listed 117 patella tendon autografts, 59 patella tendon allografts, 25 Achilles tendon allografts,
and 3 combination autologous/allogenic grafts.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Types of outcome measures
We clarified that our top primary outcome was ’subjectively-rated knee function’, with an emphasis on the use of validated patient-
rated scores. While these scores may include a quality of life aspect, we split off knee function from general quality of life outcome
measures, such as the SF-36. We made the latter a new secondary outcome.
We included arthrofibrosis, cyclops lesion and adhesions that required further surgery as named adverse events.
In the protocol, we planned to assess outcomes in the short term (within six months of ACL reconstruction), intermediate term (between
six months and two years of ACL reconstruction), and long term (more than two years after ACL reconstruction). However, based on
the distribution of data, we decided in the review to present the follow-up at one year, two years and over two years (long-term results).
Unit of analysis issues
There were no unit of analysis issues relating to the inclusion of people with bilateral ACL reconstruction. However, we made explicit
our awareness of other unit of analysis issues, such as those relating to the use of more than one screw per knee and measurement of
outcomes at different times.
Data analysis
Instead of expressing estimate effects as the number needed to treat for an additional beneficial outcome (NNTB) or the number needed
to treat for an additional harmful outcome (NNTH) as in our protocol, we opted for the approach taken in the ’Summary of findings’
table.
Because of inconsistencies present in included studies, we did not carry out our plan to investigate the potential impact of missing data
on the findings of the review or conduct worst- and best-case scenario analyses.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Absorbable Implants [adverse effects]; ∗Anterior Cruciate Ligament Injuries; ∗Bone Screws [adverse effects]; Anterior Cruciate Liga-
ment Reconstruction [instrumentation; ∗methods]; Joint Instability [etiology]; Knee Joint; Metals [adverse effects]; Patellar Ligament
[transplantation]; Randomized Controlled Trials as Topic; Range of Motion, Articular; Tendons [∗transplantation]; Treatment Out-
come
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